
  
    
      
        Background_NNP
        The_DT ability_NN to_TO measure_VB the_DT expression_NN of_IN thousands_NNS of_IN
        genes_NNS at_IN once_RB using_VBG microarrays_NNS has_VBZ opened_VBN new_JJ areas_NNS of_IN
        research_NN ,_, including_VBG global_JJ examination_NN of_IN the_DT effects_NNS of_IN
        perturbations_NNS on_IN cells_NNS or_CC animals_NNS and_CC the_DT classification_NN of_IN
        tumors_NNS by_IN their_PRP$ pattern_NN of_IN gene_NN expression_NN ._. Microarrays_NNP
        using_VBG cDNAs_NNS [_NN 1_CD 2_CD ]_NN and_CC oligonucleotides_NNS [_NN 3_CD 4_CD 5_CD ]_NN have_VBP
        both_DT proven_VBN valuable_JJ ._.
        Commercially_NNP available_JJ oligonucleotide_NN microarrays_NNS
        provide_VBP a_DT standardized_JJ tool_NN that_WDT allows_VBZ assay_NN of_IN thousands_NNS
        of_IN mRNAs_NNS at_IN one_CD time_NN ._. Affymetrix_NNP GeneChips_NNP ®_NN contain_VB pairs_NNS
        of_IN 25_CD -_: nucleotide_NN sequences_NNS (_( probe_NN pairs_NNS )_) synthesized_JJ on_IN
        silica_NN wafers_NNS ;_: one_CD of_IN each_DT pair_NN exactly_RB matches_VBZ the_DT
        sequence_NN of_IN interest_NN and_CC the_DT other_JJ contains_VBZ a_DT single_JJ
        mismatching_VBG nucleotide_NN in_IN the_DT center_NN [_NN 6_CD 7_CD ]_NN ._. A_DT single_JJ
        sequence_NN is_VBZ queried_VBN by_IN a_DT group_NN of_IN 8_CD to_TO 16_CD probe_NN pairs_NNS that_WDT
        constitute_VBP a_DT probe_NN set_VBN ._. RNA_NNP from_IN the_DT sample_NN is_VBZ converted_VBN to_TO
        double-stranded_JJ cDNA_NN and_CC then_RB labeled_VBN by_IN 
        in_IN vitro_NN transcription_NN with_IN
        biotinylated_JJ nucleotides_NNS ._. The_DT biotinylated_JJ cRNA_NN is_VBZ
        hybridized_JJ to_TO the_DT GeneChip_NNP ®_NN ,_, unhybridized_JJ material_NN is_VBZ
        washed_VBN off_RP ,_, and_CC the_DT signal_NN is_VBZ detected_VBN using_VBG
        fluorescein-labeled_JJ Streptavidin_NNP [_NN 8_CD ]_NN ._.
        The_DT standard_JJ Affymetrix_NNP protocol_NN [_NN 8_CD ]_NN uses_VBZ as_IN starting_VBG
        material_NN 10_CD μg_NN of_IN total_JJ RNA_NNP ,_, from_IN which_WDT biotinylated_JJ cRNA_NN
        is_VBZ synthesized_JJ ._. This_DT can_MD limit_VB the_DT use_NN of_IN this_DT system_NN for_IN
        small_JJ samples_NNS from_IN biopsies_NNS ,_, laser_NN capture_NN microdissection_NN
        or_CC tissues_NNS from_IN model_NN organisms_NNS such_JJ as_IN mice_NNS ._. Mahadevappa_NNP
        and_CC Warrington_NNP [_NN 9_CD ]_NN examined_VBD the_DT effect_NN of_IN using_VBG less_RBR
        biotinylated_JJ cRNA_NN in_IN the_DT hybridization_NN ._. Hybridization_NNP
        reactions_NNS that_WDT contained_VBD the_DT recommended_VBD 10_CD μg_NN of_IN cRNA_NN
        (_( from_IN human_JJ endometrium_NN adenocarcinoma_NN cells_NNS )_) detected_VBD 35_CD %_NN
        of_IN the_DT 1779_CD transcripts_NNS on_IN the_DT GeneChip_NNP ®_NN ._. Reducing_VBG the_DT
        amount_NN of_IN cRNA_NN in_IN the_DT hybridization_NN to_TO 5_CD μg_NN reduced_VBD the_DT
        fraction_NN detected_VBD to_TO 30_CD %_NN ,_, and_CC further_JJ reducing_VBG the_DT cRNA_NN to_TO
        2_CD ._. 5_CD μg_NN allowed_VBD detection_NN of_IN only_RB 27_CD %_NN of_IN the_DT sequences_NNS [_NN 9_CD ]_NN
        ._. Ohyama_NNP et_CC al_NN ._. [_NN 10_CD ]_NN tested_VBD a_DT modified_VBN protocol_NN for_IN
        synthesizing_VBG biotinylated_JJ cRNA_NN from_IN very_RB small_JJ amounts_NNS of_IN
        starting_VBG material_NN ._. Total_NNP RNA_NNP from_IN laser_NN capture_NN
        microdissected_JJ human_JJ oral_JJ cancer_NN tissues_NNS was_VBD converted_VBN into_IN
        cDNA_NN and_CC transcribed_JJ 
        in_IN vitro_NN ;_: the_DT resulting_VBG cRNA_NN was_VBD
        converted_VBN into_IN cDNA_NN and_CC transcribed_JJ 
        in_IN vitro_NN a_DT second_JJ time_NN to_TO generate_VB
        more_JJR cRNA_NN ;_: this_DT cRNA_NN was_VBD again_RB converted_VBN into_IN cDNA_NN and_CC
        biotinylated_JJ cRNA_NN was_VBD synthesized_JJ by_IN a_DT third_JJ 
        in_IN vitro_NN transcription_NN ._. This_DT
        procedure_NN produced_VBD 10_CD μg_NN of_IN biotinylated_JJ cRNA_NN from_IN 0_CD ._. 1_CD μg_NN
        of_IN starting_VBG total_JJ RNA_NNP ._. Hybridization_NNP with_IN 10_CD μg_NN of_IN
        biotinylated_JJ cRNA_NN generated_VBN by_IN this_DT amplification_NN protocol_NN
        allowed_VBD detection_NN of_IN 30_CD %_NN of_IN the_DT 7000_CD transcripts_NNS on_IN the_DT
        HuGeneFL_NNP GeneChip_NNP ®_NN [_NN 10_CD ]_NN ._. In_IN contrast_NN ,_, hybridization_NN
        with_IN 10_CD μg_NN of_IN biotinylated_JJ cRNA_NN generated_VBN by_IN the_DT standard_JJ
        protocol_NN from_IN total_JJ RNA_NNP extracted_VBD from_IN similar_JJ tissues_NNS
        resulted_VBD in_IN detection_NN of_IN 35_CD %_NN of_IN the_DT transcripts_NNS being_VBG
        detected_VBN [_NN 10_CD ]_NN ._.
        Rather_RB than_IN focusing_VBG upon_IN the_DT number_NN of_IN transcripts_NNS
        detected_VBD ,_, the_DT real_JJ test_NN of_IN a_DT microarray_NN protocol_NN is_VBZ the_DT
        extent_NN to_TO which_WDT it_PRP allows_VBZ differences_NNS in_IN expression_NN levels_NNS
        to_TO be_VB reliably_RB detected_VBN ._. The_DT biological_JJ variability_NN
        inherent_JJ in_IN most_JJS experimental_JJ models_NNS ,_, including_VBG both_DT
        genetic_JJ and_CC environmental_JJ differences_NNS between_IN animals_NNS or_CC
        even_RB replicate_VB cell_NN cultures_NNS ,_, limits_VBZ the_DT detection_NN of_IN such_JJ
        differences_NNS ._. Additional_JJ variability_NN in_IN the_DT treatment_NN and_CC
        handling_NN of_IN the_DT models_NNS and_CC in_IN the_DT RNA_NNP extraction_NN typically_RB
        occur_VB outside_IN the_DT microarray_NN laboratory_NN ,_, and_CC can_MD be_VB reduced_VBN
        (_( but_CC not_RB eliminated_VBN )_) by_IN careful_JJ experimental_JJ design_NN ._. There_EX
        is_VBZ the_DT potential_NN for_IN introducing_VBG additional_JJ technical_JJ
        variability_NN during_IN the_DT synthesis_NN of_IN biotinylated_JJ cRNA_NN ._. In_IN
        evaluating_VBG a_DT new_JJ protocol_NN or_CC comparing_VBG existing_VBG protocols_NNS ,_,
        measures_NNS such_JJ as_IN the_DT yield_NN of_IN cRNA_NN or_CC the_DT fraction_NN of_IN probe_NN
        sets_NNS detected_VBD can_MD be_VB useful_JJ ,_, but_CC the_DT key_JJ measure_NN is_VBZ the_DT
        extent_NN to_TO which_WDT differences_NNS in_IN gene_NN expression_NN can_MD be_VB
        detected_VBN in_IN a_DT realistic_JJ experiment_NN ._.
        We_PRP have_VBP systematically_RB explored_JJ the_DT use_NN of_IN smaller_JJR
        amounts_NNS of_IN starting_VBG material_NN (_( total_JJ RNA_NNP )_) in_IN a_DT model_NN
        experiment_NN that_WDT retains_VBZ the_DT individual-to-individual_JJ
        biological_JJ variation_NN of_IN a_DT real_JJ experiment_NN ._. This_DT allowed_VBN us_PRP
        to_TO compare_VB technical_JJ variability_NN to_TO the_DT biological_JJ
        variability_NN in_IN a_DT typical_JJ experiment_NN ._. We_PRP started_VBD with_IN total_JJ
        RNA_NNP from_IN individual_JJ rats_NNS exposed_VBN to_TO two_CD different_JJ
        nutritional_JJ regimens_NNS and_CC used_VBN serial_NN dilutions_NNS of_IN the_DT RNA_NNP
        to_TO simulate_VBP experimental_JJ systems_NNS that_WDT provide_VBP smaller_JJR
        quantities_NNS of_IN total_JJ RNA_NNP ._. We_PRP used_VBD the_DT Rat_NNP Genome_NNP RGU_NNP 34_CD A_DT
        GeneChip_NNP ®_NN for_IN all_DT of_IN the_DT experiments_NNS ._. Our_PRP$ first_JJ goal_NN was_VBD to_TO
        determine_VB a_DT reasonable_JJ lower_JJR bound_JJ for_IN total_JJ RNA_NNP that_WDT could_MD
        successfully_RB be_VB used_VBN in_IN the_DT standard_JJ protocol_NN ._. Second_JJ ,_, we_PRP
        wanted_VBD to_TO test_VB a_DT modified_VBN version_NN of_IN the_DT Ohyama_NNP
        amplification_NN procedure_NN [_NN 10_CD ]_NN that_IN we_PRP thought_VBD would_MD be_VB
        faster_RBR ,_, simpler_JJR and_CC less_RBR likely_JJ to_TO skew_NN results_NNS due_JJ to_TO
        truncation_NN of_IN the_DT labeled_VBN cRNA_NN ._. We_PRP examined_VBD the_DT variability_NN
        and_CC the_DT ability_NN to_TO detect_VB significant_JJ changes_NNS between_IN
        animals_NNS fed_VBD the_DT 2_CD different_JJ dietary_JJ regimens_NNS when_WRB different_JJ
        amounts_NNS of_IN starting_VBG material_NN and_CC different_JJ protocols_NNS were_VBD
        used_VBN ._.
      
      
        Results_NNS
        
          Yields_NNS and_CC quality_NN of_IN cRNA_NN
          The_DT standard_JJ protocol_NN uses_VBZ 10_CD μg_NN of_IN total_JJ RNA_NNP to_TO
          produce_VB biotinylated_JJ cRNA_NN [_NN 8_CD ]_NN ._. In_IN our_PRP$ experiment_NN ,_, the_DT
          average_JJ yield_NN of_IN biotinylated_JJ cRNA_NN was_VBD 97_CD μg_NN (_( ±_NN 41_CD μg_NN ;_:
          mean_VB ±_NN standard_JJ deviation_NN )_) when_WRB we_PRP started_VBD with_IN 10_CD μg_NN of_IN
          RNA_NNP and_CC used_VBN one-half_NN of_IN the_DT double_RB stranded_VBN cDNA_NN product_NN
          in_IN the_DT 
          in_IN vitro_NN transcription_NN reaction_NN ._.
          Starting_VBG with_IN 2_CD μg_NN of_IN total_JJ RNA_NNP ,_, we_PRP obtained_VBD an_DT average_NN
          of_IN 50_CD μg_NN (_( ±_NN 20_CD μg_NN ;_: standard_JJ deviation_NN )_) of_IN biotinylated_JJ
          cRNA_NN after_IN using_VBG all_DT of_IN the_DT double_RB stranded_VBN cDNA_NN product_NN
          in_IN the_DT 
          in_IN vitro_NN transcription_NN reaction_NN ._.
          The_DT 1_CD μg_NN pooled_VBN samples_NNS produced_VBD an_DT average_NN of_IN 5_CD ._. 6_CD μg_NN of_IN
          biotinylated_JJ cRNA_NN (_( yields_NNS ranged_VBD from_IN 2_CD ._. 4_CD μg_NN to_TO 7_CD ._. 7_CD μg_NN )_) ._.
          No_DT difference_NN in_IN yield_NN was_VBD observed_VBN between_IN the_DT samples_NNS
          prepared_VBN with_IN the_DT ENZO_NNP and_CC Epicentre_NNP T_NN 7_CD polymerases_NNS ._. This_DT
          lack_NN of_IN difference_NN led_VBD us_PRP to_TO select_VB the_DT Epicentre_NNP
          Ampliscribe_NNP ™_NN T_NN 7_CD High_NNP Yield_NNP Kit_NNP for_IN the_DT extra_JJ 
          in_IN vitro_NN transcription_NN step_NN to_TO
          decrease_VB expense_NN ._.
          The_DT standard_JJ Affymetrix_NNP protocol_NN uses_VBZ 15_CD μg_NN of_IN
          biotinylated_JJ cRNA_NN to_TO make_VB a_DT 300_CD μl_NN hybridization_NN
          cocktail_NN ,_, of_IN which_WDT 200_CD μl_NN is_VBZ injected_VBN into_IN the_DT chip_NN for_IN
          hybridization_NN ._. The_DT yield_NN of_IN cRNA_NN from_IN both_DT 10_CD μg_NN and_CC 2_CD μg_NN
          of_IN starting_VBG RNA_NNP (_( above_IN )_) were_VBD more_JJR than_IN sufficient_JJ for_IN
          this_DT ._. Because_IN yields_NNS of_IN cRNA_NN starting_VBG from_IN 1_CD μg_NN total_JJ RNA_NNP
          were_VBD too_RB low_JJ ,_, we_PRP decided_VBD to_TO use_VB an_DT additional_JJ
          amplification_NN step_NN for_IN RNA_NNP samples_NNS less_JJR than_IN 1_CD μg_NN ._. Our_PRP$
          modified_VBN protocol_NN uses_VBZ the_DT initial_NN 
          in_IN vitro_NN transcribed_JJ cRNA_NN as_IN
          starting_VBG material_NN for_IN a_DT second_JJ round_NN of_IN cDNA_NN synthesis_NN
          and_CC 
          in_IN vitro_NN transcription_NN (_( Methods_NNP )_) ._.
          The_DT cRNA_NN yields_NNS from_IN the_DT 0_CD ._. 5_CD μg_NN samples_NNS with_IN our_PRP$ protocol_NN
          averaged_VBD 32_CD μg_NN (_( ±_NN 13_CD μg_NN )_) ,_, more_RBR than_IN enough_RB for_IN the_DT
          standard_JJ hybridizations_NNS ._. The_DT cRNA_NN yields_NNS from_IN the_DT 0_CD ._. 1_CD μg_NN
          samples_NNS using_VBG the_DT same_JJ protocol_NN averaged_VBD 10_CD μg_NN with_IN a_DT
          range_NN from_IN 5_CD to_TO 21_CD μg_NN ,_, so_IN some_DT samples_NNS had_VBD too_RB little_JJ to_TO
          prepare_VB a_DT hybridization_NN mixture_NN at_IN the_DT same_JJ
          concentration_NN ._. Therefore_RB ,_, the_DT 0_CD ._. 1_CD μg_NN samples_NNS were_VBD
          hybridized_JJ to_TO GeneChips_NNP ®_NN using_VBG 5_CD μg_NN to_TO 7_CD ._. 5_CD μg_NN of_IN cRNA_NN to_TO
          assess_VB results_NNS using_VBG these_DT limited_JJ amounts_NNS ._.
          Aliquots_NNP of_IN the_DT biotinylated_JJ cRNA_NN samples_NNS were_VBD
          analyzed_VBN by_IN agarose_NN gel_NN electrophoresis_NNS to_TO check_VB the_DT
          quality_NN and_CC length_NN ._. The_DT cRNA_NN for_IN both_DT the_DT 10_CD μg_NN and_CC 2_CD μg_NN
          samples_NNS ranged_VBD from_IN 200_CD to_TO over_IN 2_CD ,_, 000_CD bases_NNS (_( before_IN
          fragmentation_NN )_) ._. The_DT cRNA_NN from_IN the_DT 0_CD ._. 5_CD μg_NN sample_NN prepared_VBN
          by_IN the_DT amplification_NN protocol_NN ranged_VBD from_IN 200_CD to_TO 850_CD
          bases_NNS ,_, a_DT considerable_JJ decrease_NN in_IN maximum_NN length_NN ._. The_DT 0_CD ._. 1_CD
          μg_NN samples_NNS were_VBD too_RB faint_JJ to_TO judge_VB their_PRP$ size_NN range_NN ._.
        
        
          Changes_NNS in_IN sensitivity_NN as_IN measured_VBN by_IN detection_NN of_IN
          probe_NN sets_NNS
          For_IN a_DT particular_JJ tissue_NN or_CC cell_NN type_NN ,_, the_DT percent_NN
          present_JJ and_CC the_DT scaling_VBG factors_NNS should_MD be_VB similar_JJ among_IN
          all_DT arrays_NNS in_IN the_DT same_JJ experiment_NN in_IN the_DT absence_NN of_IN
          variability_NN introduced_VBN by_IN preparation_NN ,_, labeling_VBG ,_, and_CC
          handling_NN of_IN the_DT individual_JJ samples_NNS ._. Because_IN we_PRP created_VBD
          groups_NNS of_IN samples_NNS diluted_VBN from_IN the_DT same_JJ individual_JJ RNA_NNP
          preparations_NNS ,_, any_DT group_NN differences_NNS reflect_VBP differences_NNS
          in_IN labeling_VBG and_CC handling_NN of_IN the_DT samples_NNS ._. We_PRP used_VBD the_DT
          percent_NN of_IN probe_NN sets_NNS called_VBD present_JJ and_CC the_DT scaling_VBG
          factor_NN (_( see_VB Methods_NNP )_) for_IN an_DT initial_JJ comparison_NN among_IN the_DT
          groups_NNS (_( Table_NNP 1_LS )_) ._. The_DT 2_CD μg_NN samples_NNS were_VBD essentially_RB
          equivalent_JJ to_TO the_DT 10_CD μg_NN samples_NNS by_IN these_DT measures_NNS (_( Table_NNP
          1_LS )_) ._. For_IN the_DT amplified_VBN samples_NNS (_( 0_CD ._. 5_LS μg_NN and_CC 0_CD ._. 1_CD μg_NN starting_VBG
          material_NN )_) ,_, the_DT percent_NN present_RB was_VBD decreased_VBN and_CC the_DT
          scaling_VBG factor_NN increased_VBD compared_VBN to_TO the_DT non-amplified_JJ
          samples_NNS ._. The_DT percent_NN present_RB dropped_VBD to_TO 30_CD ._. 2_LS %_NN in_IN the_DT 0_CD ._. 5_CD
          μg_NN group_NN (_( 78_CD %_NN of_IN that_DT detected_VBD in_IN the_DT 10_CD μg_NN group_NN )_) and_CC
          even_RB further_RBR ,_, to_TO 24_CD ._. 5_LS %_NN ,_, for_IN the_DT 0_CD ._. 1_CD μg_NN samples_NNS ._. Two_CD other_JJ
          quality_NN control_NN measures_NNS ,_, noise_NN and_CC background_NN ,_, were_VBD
          similar_JJ across_IN all_DT 30_CD GeneChips_NNP ®_NN (_( data_NNS not_RB shown_VBN )_) ._.
          If_IN the_DT decrease_NN in_IN starting_VBG amount_NN of_IN RNA_NNP or_CC the_DT
          differences_NNS in_IN protocol_NN had_VBD no_DT effect_NN on_IN the_DT outcome_NN ,_, the_DT
          signals_NNS from_IN all_DT of_IN the_DT reduced_VBN RNA_NNP sample_NN size_NN groups_NNS
          would_MD be_VB distributed_VBN similarly_RB to_TO the_DT 10_CD μg_NN group_NN ._. SAS_NNP
          was_VBD used_VBN to_TO analyze_VB the_DT signals_NNS from_IN each_DT RNA_NNP sample_NN size_NN
          group_NN ._. Probe_NNP sets_NNS were_VBD separated_VBN by_IN detection_NN call_NN
          (_( absent_JJ ,_, present_JJ and_CC marginal_JJ )_) and_CC analysis_NN was_VBD performed_VBN
          separately_RB for_IN each_DT group_NN (_( only_RB 2_CD %_NN of_IN the_DT probe_NN sets_NNS were_VBD
          called_VBN marginal_JJ ;_: these_DT were_VBD omitted_VBN from_IN Table_NNP 2_LS )_) ._.
          Signals_NNP for_IN the_DT 2_CD μg_NN samples_NNS are_VBP distributed_VBN similarly_RB to_TO
          the_DT 10_CD μg_NN samples_NNS (_( Table_NNP 2_LS )_) ._. For_IN the_DT amplified_VBN samples_NNS
          the_DT range_NN of_IN signals_NNS is_VBZ increased_VBN and_CC the_DT distribution_NN is_VBZ
          shifted_VBN toward_IN higher_JJR signal_NN values_NNS ._. The_DT decrease_NN in_IN
          percent_NN of_IN probe_NN sets_NNS called_VBD present_JJ on_IN the_DT GeneChips_NNP
          ®_NN from_IN the_DT amplified_VBN samples_NNS has_VBZ the_DT effect_NN of_IN lowering_VBG
          the_DT average_JJ signal_NN on_IN the_DT chip_NN ,_, requiring_VBG a_DT higher_JJR
          scaling_VBG factor_NN (_( Table_NNP 1_LS )_) ._. This_DT results_NNS in_IN an_DT inflation_NN of_IN
          the_DT signal_NN values_NNS for_IN all_DT of_IN the_DT probe_NN sets_NNS on_IN these_DT
          arrays_NNS ._.
          To_TO examine_VB the_DT effects_NNS of_IN starting_VBG with_IN smaller_JJR
          amounts_NNS of_IN RNA_NNP on_IN the_DT variability_NN in_IN detection_NN of_IN probe_NN
          sets_NNS ,_, we_PRP examined_VBD the_DT number_NN of_IN probe_NN sets_NNS that_WDT changed_VBD
          from_IN present_JJ to_TO absent_VB or_CC from_IN absent_JJ to_TO present_VB when_WRB
          comparing_VBG the_DT 10_CD μg_NN sample_NN to_TO the_DT smaller_JJR RNA_NNP samples_NNS
          from_IN the_DT same_JJ animal_NN (_( Table_NNP 3_LS )_) ._. The_DT average_JJ number_NN of_IN
          probe_NN sets_NNS called_VBD present_JJ on_IN the_DT 10_CD μg_NN chip_NN and_CC absent_JJ on_IN
          the_DT 2_CD μg_NN chip_NN (_( P_NN 
          10_CD to_TO A_DT )_) and_CC called_VBN absent_JJ on_IN the_DT 10_CD
          μg_NN chip_NN and_CC present_JJ on_IN the_DT 2_CD μg_NN chip_NN (_( A_DT 
          10_CD to_TO P_NN )_) changes_NNS were_VBD similar_JJ ._. The_DT
          bulk_NN of_IN these_DT changes_NNS were_VBD for_IN probe_NN sets_NNS with_IN lower_JJR
          levels_NNS of_IN expression_NN (_( Table_NNP 3_LS )_) ._. This_DT distribution_NN is_VBZ
          consistent_JJ with_IN the_DT greater_JJR variability_NN seen_VBN in_IN probe_NN
          sets_NNS with_IN low_JJ signals_NNS (_( see_VB below_IN )_) ;_: there_EX is_VBZ no_DT
          significant_JJ loss_NN of_IN low-level_JJ transcripts_NNS in_IN the_DT 2_CD μg_NN
          samples_NNS ._.
          Because_IN the_DT amplified_VBN samples_NNS (_( from_IN 0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN
          starting_VBG material_NN )_) have_VBP a_DT decrease_NN in_IN the_DT percent_NN of_IN
          probe_NN sets_NNS called_VBD present_JJ (_( Table_NNP 1_LS )_) ,_, the_DT number_NN of_IN probe_NN
          sets_NNS called_VBD present_JJ in_IN the_DT 10_CD μg_NN samples_NNS and_CC absent_JJ in_IN
          the_DT amplified_VBN sample_NN from_IN the_DT same_JJ animal_NN must_MD be_VB greater_JJR
          than_IN the_DT number_NN called_VBD absent_JJ in_IN the_DT 10_CD μg_NN sample_NN and_CC
          present_JJ in_IN the_DT amplified_VBN samples_NNS (_( Table_NNP 3_LS )_) ._. Loss_NN of_IN
          signal_NN is_VBZ expected_VBN in_IN low-level_JJ transcripts_NNS for_IN the_DT
          amplified_VBN samples_NNS because_IN of_IN the_DT decrease_NN in_IN starting_VBG
          material_NN ,_, but_CC probe_NN sets_NNS present_JJ in_IN the_DT 10_CD μg_NN and_CC absent_JJ
          in_IN the_DT amplified_VBN samples_NNS are_VBP not_RB confined_VBN to_TO those_DT probe_NN
          sets_NNS with_IN low_JJ signals_NNS ._. Forty-three_NNP percent_NN of_IN the_DT probes_NNS
          not_RB detected_VBD in_IN the_DT amplified_VBN samples_NNS have_VBP a_DT signal_NN
          greater_JJR than_IN 600_CD in_IN the_DT 10_CD μg_NN sample_NN ,_, and_CC 5_CD %_NN have_VBP a_DT
          signal_NN of_IN at_IN least_JJS 3200_CD ._. In_IN comparison_NN ,_, for_IN the_DT 2_CD μg_NN
          samples_NNS ,_, only_RB 14_CD %_NN of_IN the_DT probe_NN sets_NNS present_JJ in_IN the_DT 10_CD μg_NN
          sample_NN and_CC absent_JJ in_IN the_DT 2_CD μg_NN sample_NN had_VBD signals_NNS greater_JJR
          than_IN 600_CD ,_, and_CC none_NN had_VBD signals_NNS over_IN 3200_CD ._.
          The_DT probe_NN sets_NNS changing_VBG from_IN absent_JJ in_IN the_DT 10_CD μg_NN
          samples_NNS to_TO present_VB in_IN the_DT amplified_VBN samples_NNS (_( Table_NNP 3_LS )_)
          were_VBD mostly_RB those_DT with_IN low_JJ signals_NNS in_IN the_DT 10_CD μg_NN samples_NNS ,_,
          reflecting_VBG the_DT greater_JJR noise_NN found_VBD in_IN probe_NN sets_NNS with_IN low_JJ
          signals_NNS (_( Figure_NN 1_LS )_) ._.
        
        
          Biological_NNP and_CC technical_JJ variability_NN
          The_DT Affymetrix_NNP MAS_NNP 5_CD comparison_NN analysis_NN tool_NN was_VBD used_VBN
          to_TO compare_VB expression_NN levels_NNS between_IN pairs_NNS of_IN GeneChips_NNP
          ®_NN ._. This_DT analysis_NN directly_RB compares_VBZ two_CD arrays_NNS at_IN each_DT
          individual_JJ probe_NN pair_NN rather_RB than_IN merely_RB comparing_VBG the_DT
          signal_NN computed_JJ from_IN all_DT of_IN the_DT probe_NN pairs_NNS for_IN a_DT probe_NN
          set_VBD [_NN 11_CD ]_NN ._. Comparisons_NNP among_IN the_DT 10_CD μg_NN samples_NNS from_IN
          different_JJ animals_NNS within_IN each_DT of_IN the_DT treatment_NN groups_NNS
          showed_VBD that_IN the_DT biological_JJ (_( between_IN animal_NN )_) plus_CC random_JJ
          technical_JJ variability_NN is_VBZ considerable_JJ (_( Table_NNP 4_CD ,_, 10_CD 
          vs_NNS ._. 10_CD )_) ._. There_EX was_VBD an_DT average_NN of_IN
          over_IN 700_CD apparent_JJ differences_NNS in_IN expression_NN level_NN between_IN
          pairs_NNS of_IN GeneChips_NNP ®_NN within_IN a_DT single_JJ treatment_NN group_NN ,_, 12_CD %_NN
          of_IN which_WDT were_VBD 2_CD -_: fold_VB or_CC greater_JJR ._. The_DT number_NN of_IN increases_NNS
          and_CC decreases_NNS were_VBD comparable_JJ ,_, suggesting_VBG random_JJ rather_RB
          than_IN systematic_JJ changes_NNS ._. Increases_NNS and_CC decreases_NNS were_VBD
          randomly_RB distributed_VBN across_IN probe_NN sets_NNS with_IN different_JJ
          levels_NNS of_IN expression_NN ._. This_DT can_MD be_VB visualized_JJ as_IN a_DT scatter_NN
          plot_NN comparing_VBG two_CD different_JJ 10_CD μg_NN samples_NNS both_DT from_IN the_DT
          vitamin-deficient_JJ group_NN (_( Figure_NN 1_CD a_DT and_NN 1_CD b_SYM )_) ;_: results_NNS are_VBP
          similar_JJ for_IN a_DT pair_NN of_IN control_NN samples_NNS ._. There_EX is_VBZ
          noticeable_JJ scatter_NN from_IN the_DT expected_VBN diagonal_NN ,_, and_CC the_DT
          scatter_NN is_VBZ greatly_RB exacerbated_VBN at_IN low_JJ signal_NN levels_NNS ._. This_DT
          shows_VBZ variability_NN between_IN animals_NNS within_IN a_DT single_JJ
          treatment_NN group_NN (_( plus_CC the_DT technical_JJ variability_NN in_IN
          handling_VBG two_CD samples_NNS ,_, even_RB with_IN the_DT same_JJ protocol_NN )_) ._.
          Figure_NN 1_CD b_SYM is_VBZ the_DT same_JJ pair_NN of_IN GeneChips_NNP ®_NN but_CC is_VBZ
          restricted_VBN to_TO probe_VB sets_NNS that_WDT were_VBD called_VBN present_JJ in_IN the_DT
          first_JJ sample_NN (_( Sample_NNP A_DT ,_, x-axis_JJ )_) ._. Analysis_NNP of_IN the_DT signals_NNS
          for_IN all_DT of_IN the_DT 10_CD μg_NN arrays_NNS shows_VBZ that_IN 59_CD %_NN of_IN the_DT probe_NN
          sets_NNS have_VBP signals_NNS below_IN 300_CD ,_, and_CC that_IN 89_CD %_NN of_IN these_DT are_VBP
          called_VBN absent_JJ ._. Removing_NNP the_DT probe_NN sets_NNS called_VBD absent_JJ from_IN
          further_JJ analyses_NNS removes_VBZ most_JJS of_IN the_DT variability_NN seen_VBN in_IN
          this_DT low_JJ signal_NN range_NN ._. The_DT data_NNS in_IN Table_NNP 4_CD were_VBD limited_VBN to_TO
          probe_VB sets_NNS that_WDT were_VBD called_VBN present_JJ in_IN the_DT baseline_NN
          sample_NN for_IN each_DT comparison_NN to_TO avoid_VB the_DT noise_NN of_IN low_JJ
          signal_NN absent_JJ and_CC marginal_JJ calls_VBZ (_( cf_NN ._. Figure_NN 1_LS )_) ._.
          GeneChips_NNP ®_NN from_IN the_DT lower_JJR RNA_NNP sample_NN size_NN groups_NNS were_VBD
          compared_VBN to_TO the_DT 10_CD μg_NN chip_NN from_IN the_DT same_JJ animal_NN ;_: these_DT
          comparisons_NNS represent_VBP technical_JJ variation_NN only_RB ,_, because_IN
          the_DT RNAs_NNP were_VBD dilutions_NNS from_IN the_DT same_JJ RNA_NNP preparations_NNS ._.
          To_TO compare_VB variability_NN introduced_VBN by_IN the_DT same_JJ labeling_VBG
          protocol_NN with_IN different_JJ amounts_NNS of_IN starting_VBG material_NN ,_, in_IN
          Figure_NN 1_CD c_SYM and_CC 1_CD d_SYM we_PRP compared_VBD a_DT 2_CD μg_NN sample_NN to_TO a_DT 10_CD μg_NN
          sample_NN from_IN the_DT 
          same_JJ animal_NN (_( sample_NN A_DT ,_, x-axis_JJ in_IN a_DT
          and_NN b_SYM )_) ._. As_IN can_MD be_VB seen_VBN ,_, the_DT variation_NN due_JJ to_TO differences_NNS
          in_IN sample_NN size_NN plus_CC the_DT technical_JJ variability_NN is_VBZ less_JJR
          than_IN the_DT between-animal_JJ variation_NN shown_VBN in_IN Figure_NN 1_CD a_DT and_NN
          1_CD b_SYM ._. The_DT 2_CD μg_NN arrays_NNS have_VBP an_DT average_NN of_IN 134_CD decreases_NNS and_CC
          136_CD increases_NNS when_WRB compared_VBN to_TO the_DT 10_CD μg_NN samples_NNS from_IN the_DT
          same_JJ animals_NNS (_( Table_NNP 5_CD ,_, 2_CD 
          vs_NNS ._. 10_CD )_) ;_: this_DT reflects_VBZ technical_JJ
          variability_NN of_IN samples_NNS prepared_VBN by_IN the_DT same_JJ protocol_NN from_IN
          different_JJ amounts_NNS of_IN starting_VBG material_NN ._. Only_RB 4_CD %_NN of_IN these_DT
          changes_NNS had_VBD a_DT magnitude_NN of_IN 2_CD -_: fold_VB or_CC greater_JJR ,_, for_IN an_DT
          average_NN of_IN 10_CD changes_NNS per_IN chip_NN ._. This_DT variability_NN was_VBD much_RB
          smaller_JJR than_IN the_DT biological_JJ variation_NN seen_VBN between_IN pairs_NNS
          of_IN arrays_NNS from_IN different_JJ animals_NNS (_( 10_CD μg_NN arrays_NNS ,_, Table_NNP 4_LS )_) ._.
          There_EX were_VBD a_DT balanced_JJ number_NN of_IN increases_NNS and_CC decreases_NNS ._.
          The_DT changes_NNS in_IN the_DT 2_CD μg_NN samples_NNS appear_VBP random_JJ :_: different_JJ
          probe_NN sets_NNS change_VBP in_IN different_JJ comparisons_NNS ._. Only_RB 8_CD probe_NN
          sets_NNS changed_VBN consistently_RB (_( in_IN at_IN least_JJS 5_CD of_IN the_DT 6_CD
          comparisons_NNS )_) ._.
          To_TO examine_VB variability_NN introduced_VBN by_IN the_DT amplification_NN
          protocol_NN ,_, we_PRP compared_VBD a_DT 0_CD ._. 5_CD μg_NN sample_NN to_TO a_DT 10_CD μg_NN sample_NN
          from_IN the_DT same_JJ animal_NN (_( Figures_NNS 2_CD a_DT and_NN 2_CD b_SYM )_) ._. This_DT comparison_NN
          includes_VBZ both_DT systematic_JJ and_CC random_JJ variability_NN
          introduced_VBN by_IN the_DT amplification_NN protocol_NN used_VBN for_IN the_DT 0_CD ._. 5_CD
          μg_NN sample_NN ._. There_EX was_VBD much_RB more_JJR variability_NN between_IN the_DT 10_CD
          μg_NN and_CC 0_CD ._. 5_CD μg_NN samples_NNS than_IN between_IN 10_CD μg_NN and_CC 2_CD μg_NN samples_NNS
          or_CC between_IN 10_CD μg_NN samples_NNS (_( compare_VB Figures_NNS 1_CD and_CC 2_LS )_) ._. Only_RB
          probe_NN sets_NNS that_WDT were_VBD called_VBN present_JJ in_IN the_DT 10_CD μg_NN sample_NN
          have_VBP been_VBN plotted_VBD in_IN Figure_NN 2_CD b_SYM ;_: the_DT variability_NN is_VBZ still_RB
          high_JJ ._. This_DT remaining_VBG variability_NN extends_VBZ over_IN a_DT wider_JJR
          range_NN of_IN signals_NNS than_IN for_IN the_DT comparisons_NNS in_IN Figure_NN 1_CD ._.
          More_JJR of_IN the_DT probe_NN sets_NNS decreased_VBD in_IN signal_NN than_IN increased_VBN
          in_IN signal_NN ._. Many_JJ more_JJR of_IN these_DT changes_NNS are_VBP at_IN least_JJS
          2_CD -_: fold_VB ._. The_DT comparison_NN of_IN 0_CD ._. 1_CD μg_NN to_TO 10_CD μg_NN data_NNS (_( not_RB
          shown_VBN )_) is_VBZ very_RB similar_JJ to_TO the_DT 0_CD ._. 5_CD μg_NN to_TO 10_CD μg_NN
          comparison_NN ._.
          The_DT number_NN of_IN changes_NNS observed_VBD from_IN the_DT comparison_NN
          analysis_NN of_IN the_DT amplified_VBN samples_NNS to_TO the_DT 10_CD μg_NN samples_NNS is_VBZ
          significantly_RB higher_JJR than_IN for_IN the_DT 2_CD μg_NN samples_NNS ,_, and_CC there_EX
          are_VBP many_JJ more_JJR decreases_NNS than_IN increases_NNS (_( Table_NNP 5_CD ,_, 0_CD ._. 5_CD 
          vs_NNS ._. 10_CD and_CC 0_CD ._. 1_CD 
          vs_NNS ._. 10_CD )_) ._. The_DT number_NN of_IN decreases_NNS
          exceeds_VBZ 1000_CD per_IN chip_NN for_IN both_DT amplified_VBN groups_NNS ._. For_IN the_DT
          amplified_VBN samples_NNS ,_, nearly_RB 2_CD /_NN 3_CD of_IN the_DT changes_NNS are_VBP 2_CD -_: fold_VB
          or_CC greater_JJR (_( Table_NNP 5_LS )_) ,_, another_DT indication_NN of_IN the_DT increased_VBN
          variability_NN also_RB seen_VBN in_IN Figures_NNS 2_CD a_DT and_NN 2_CD b_SYM ._. The_DT changes_NNS
          for_IN the_DT amplified_VBN samples_NNS were_VBD spread_VBN evenly_RB across_IN the_DT
          range_NN of_IN signals_NNS ,_, except_IN there_EX were_VBD fewer_JJR increases_NNS seen_VBN
          in_IN the_DT low-level_JJ transcripts_NNS of_IN the_DT 0_CD ._. 1_CD μg_NN samples_NNS than_IN
          for_IN the_DT 0_CD ._. 5_CD μg_NN samples_NNS ,_, reflecting_VBG the_DT loss_NN of_IN more_JJR
          low-level_JJ transcripts_NNS in_IN the_DT 0_CD ._. 1_CD μg_NN samples_NNS ._. Decreases_NNP in_IN
          the_DT amplified_VBN samples_NNS were_VBD more_RBR consistent_JJ ,_, with_IN 727_NNP and_CC
          794_CD probe_NN sets_NNS that_WDT decreased_VBD in_IN at_IN least_JJS 7_CD of_IN the_DT 8_CD
          samples_NNS for_IN the_DT 0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN groups_NNS ,_, respectively_RB ._.
          Of_IN the_DT 727_NNP probe_NN sets_NNS that_WDT consistently_RB changed_VBN in_IN the_DT
          0_CD ._. 5_CD μg_NN samples_NNS ,_, 712_CD decreased_VBD in_IN at_IN least_JJS 6_CD of_IN the_DT 0_CD ._. 1_CD μg_NN
          samples_NNS ._. This_DT indicates_VBZ that_IN a_DT group_NN of_IN probe_NN sets_NNS is_VBZ
          being_VBG 
          systematically_RB affected_VBN in_IN both_DT of_IN
          the_DT amplified_VBN groups_NNS (_( see_VB below_IN )_) ._. A_DT percentage_NN of_IN these_DT
          decreases_NNS actually_RB result_VBP in_IN loss_NN of_IN detection_NN of_IN probe_NN
          sets_NNS ,_, 33_CD %_NN for_IN the_DT 0_CD ._. 5_CD μg_NN and_CC 43_CD %_NN for_IN the_DT 0_CD ._. 1_CD μg_NN
          samples_NNS ._.
          To_TO measure_VB the_DT level_NN of_IN variability_NN within_IN an_DT
          amplified_VBN group_NN ,_, the_DT 0_CD ._. 5_CD μg_NN arrays_NNS within_IN a_DT treatment_NN
          group_NN were_VBD compared_VBN (_( Table_NNP 4_CD ,_, 0_CD ._. 5_CD 
          vs_NNS ._. 0_CD ._. 5_LS )_) ._. The_DT number_NN of_IN changes_NNS
          within_IN the_DT 0_CD ._. 5_CD μg_NN arrays_NNS was_VBD greater_JJR than_IN within_IN the_DT 10_CD
          μg_NN arrays_NNS ,_, 932_CD per_IN chip_NN compared_VBN to_TO 709_CD for_IN the_DT 10_CD μg_NN ._.
          Not_RB only_RB were_VBD there_EX more_JJR changes_NNS ,_, a_DT larger_JJR percentage_NN of_IN
          the_DT changes_NNS were_VBD 2_CD -_: fold_VB or_CC greater_JJR ,_, 30_CD %_NN 
          vs_NNS ._. 12_CD %_NN for_IN the_DT 10_CD μg_NN samples_NNS ._. This_DT
          indicates_VBZ that_IN additional_JJ noise_NN was_VBD introduced_VBN by_IN the_DT
          amplification_NN ._.
          The_DT 0_CD ._. 1_CD μg_NN and_CC 0_CD ._. 5_CD μg_NN samples_NNS from_IN the_DT same_JJ animal_NN
          were_VBD similar_JJ to_TO each_DT other_JJ (_( Figures_NNS 2_CD c_SYM and_CC 2_CD d_SYM ,_, Table_NNP 5_LS )_) ._.
          Only_RB 16_CD %_NN of_IN the_DT differences_NNS between_IN the_DT 0_CD ._. 1_CD μg_NN and_CC 0_CD ._. 5_CD μg_NN
          groups_NNS were_VBD ≥_NN fold_VB ,_, compared_VBN to_TO 65_CD %_NN that_WDT were_VBD ≥_NN 2_CD fold_VB
          when_WRB comparing_VBG the_DT amplified_VBN samples_NNS to_TO 10_CD μg_NN samples_NNS ._.
          The_DT variation_NN between_IN the_DT amplified_VBN groups_NNS (_( 0_CD ._. 1_LS μg_NN and_CC
          0_CD ._. 5_CD μg_NN )_) is_VBZ greater_JJR than_IN the_DT variation_NN between_IN the_DT
          non-amplified_JJ groups_NNS (_( 2_CD μg_NN and_CC 10_CD μg_NN )_) ,_, and_CC decreases_NNS
          outnumber_NN increases_NNS because_IN of_IN the_DT greater_JJR loss_NN of_IN signal_NN
          in_IN the_DT 0_CD ._. 1_CD μg_NN samples_NNS ._.
        
        
          Amplification_NNP truncates_NNS the_DT 5_CD '_POS ends_NNS of_IN the_DT
          RNA_NNP
          A_DT likely_JJ cause_NN for_IN the_DT consistent_JJ decreases_NNS of_IN
          particular_JJ probe_NN sets_NNS in_IN the_DT amplified_VBN samples_NNS ,_, not_RB
          related_VBN to_TO low_JJ signal_NN level_NN ,_, is_VBZ the_DT loss_NN of_IN the_DT 5_CD '_POS end_NN of_IN
          the_DT transcript_NN ._. Synthesis_NNP of_IN cDNA_NN from_IN the_DT cRNA_NN initially_RB
          prepared_VBD is_VBZ expected_VBN to_TO lead_VB to_TO some_DT truncation_NN of_IN the_DT 5_CD '_POS
          ends_NNS of_IN the_DT original_JJ mRNA_NN ,_, due_JJ to_TO the_DT requirement_NN for_IN
          priming_VBG during_IN synthesis_NN of_IN the_DT second_JJ strand_NN ._. Indeed_RB ,_,
          the_DT cRNA_NN prepared_VBN by_IN amplification_NN from_IN the_DT 0_CD ._. 5_CD μg_NN samples_NNS
          was_VBD noticeably_RB shorter_JJR than_IN that_DT prepared_VBN by_IN the_DT standard_JJ
          protocol_NN ,_, as_IN detected_VBN by_IN agarose_NN gel_NN electrophoresis_NNS
          (_( above_IN )_) ._. Another_DT way_NN to_TO detect_VB such_JJ potential_JJ shortening_NN
          of_IN the_DT probe_NN sets_NNS is_VBZ to_TO compare_VB the_DT signals_NNS from_IN the_DT
          Affymetrix_NNP control_NN probe_NN sets_NNS ._. There_EX are_VBP 3_CD probe_NN sets_NNS
          each_DT for_IN GAPDH_NNP and_CC β-actin_JJ ,_, designated_VBN 3_CD '_POS ,_, Middle_NNP and_CC 5_CD '_POS
          based_VBN on_IN their_PRP$ relative_JJ distance_NN from_IN the_DT 3_CD '_POS end_NN of_IN the_DT
          transcript_NN ._. The_DT average_JJ 3_CD '_POS /_NN 5_CD '_POS ratio_NN for_IN both_DT 10_CD μg_NN and_CC 2_CD
          μg_NN samples_NNS was_VBD 1_CD ._. 7_CD or_CC below_IN (_( Table_NNP 1_LS )_) ,_, representing_VBG good_JJ
          samples_NNS http_NN :_: /_NN /_NN www_NN ._. affymetrix_NN ._. com_NN ._. The_DT 3_CD '_POS /_NN 5_CD '_POS ratios_NNS of_IN
          the_DT amplified_VBN samples_NNS all_DT exceeded_VBD 3_CD and_CC were_VBD as_RB high_JJ as_IN
          14_CD ,_, with_IN the_DT average_NN near_IN 6_CD for_IN GAPDH_NNP and_CC 8_CD ._. 5_CD for_IN β-actin_JJ
          (_( Table_NNP 1_LS )_) ._. These_DT ratios_NNS indicate_VBP a_DT differential_NN loss_NN of_IN
          the_DT 5_CD '_POS ends_NNS of_IN the_DT transcripts_NNS for_IN the_DT amplified_VBN samples_NNS
          (_( see_VB below_IN )_) ._.
          Examination_NNP of_IN the_DT Affymetrix_NNP comparison_NN analyses_NNS for_IN
          the_DT GAPDH_NNP and_CC β-actin_JJ probe_NN sets_NNS gives_VBZ an_DT even_RB better_JJR
          picture_NN of_IN the_DT 5_CD '_POS loss_NN ._. None_NN of_IN the_DT comparisons_NNS of_IN the_DT 2_CD
          μg_NN samples_NNS to_TO the_DT 10_CD μg_NN samples_NNS from_IN the_DT same_JJ animals_NNS
          showed_VBD a_DT significant_JJ change_NN in_IN signal_NN for_IN these_DT probe_NN
          sets_NNS ._. All_DT 8_CD of_IN the_DT 0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN samples_NNS had_VBD
          significant_JJ decreases_NNS as_IN compared_VBN to_TO the_DT 10_CD μg_NN sample_NN
          from_IN the_DT same_JJ animal_NN ,_, the_DT magnitude_NN of_IN which_WDT increases_NNS as_IN
          the_DT distance_NN of_IN the_DT probe_NN sequence_NN from_IN the_DT 3_CD '_POS end_NN of_IN the_DT
          transcript_NN increases_NNS (_( Table_NNP 6_CD )_) ._. The_DT amplified_VBN samples_NNS
          both_DT show_NN similar_JJ progressive_JJ loss_NN of_IN the_DT more_JJR 5_CD '_POS
          sequences_NNS ._. For_IN example_NN ,_, both_DT amplified_VBN samples_NNS have_VBP an_DT
          average_NN of_IN 33_CD %_NN of_IN the_DT GAPDH_NNP 3_CD '_POS signal_NN (_( mean_VB log_VB 
          2_CD ratio_NN -_: 1_CD ._. 6_CD )_) ,_, but_CC only_RB 11_CD %_NN as_IN much_JJ
          GAPDH_NNP 5_CD '_POS signal_NN (_( log_VB 
          2_CD ratio-_NN 3_CD ._. 1_LS )_) ._.
          To_TO determine_VB if_IN truncation_NN of_IN the_DT 5_CD '_POS ends_NNS of_IN the_DT RNA_NNP
          may_MD be_VB a_DT significant_JJ problem_NN for_IN many_JJ of_IN the_DT sequences_NNS on_IN
          the_DT GeneChip_NNP ®_NN ,_, the_DT distance_NN of_IN the_DT target_NN sequence_NN (_( from_IN
          which_WDT probe_VBP sets_NNS were_VBD designed_VBN )_) from_IN the_DT 3_CD '_POS end_NN of_IN the_DT
          transcripts_NNS was_VBD determined_VBN for_IN as_IN many_JJ probe_NN sets_NNS as_IN
          possible_JJ by_IN BLASTing_NNP the_DT target_NN sequence_NN against_IN the_DT 
          nr_NN database_NN (_( Figure_NN 3_LS )_) ._. We_PRP then_RB
          compared_VBD the_DT percent_NN of_IN probe_NN sets_NNS that_WDT decreased_VBD in_IN
          signal_NN at_IN different_JJ 3_CD '_POS distances_NNS ._. The_DT differences_NNS between_IN
          the_DT 2_CD μg_NN and_CC 10_CD μg_NN samples_NNS were_VBD evenly_RB distributed_VBN across_IN
          the_DT 3_CD '_POS distances_NNS (_( Figure_NN 4_LS )_) ,_, reinforcing_VBG the_DT idea_NN that_IN
          these_DT are_VBP random_JJ differences_NNS ._. In_IN contrast_NN ,_, the_DT amplified_VBN
          samples_NNS (_( 0_CD ._. 1_LS μg_NN and_CC 0_CD ._. 5_CD μg_NN )_) show_NN a_DT marked_VBN increase_NN in_IN
          the_DT percent_NN of_IN probe_NN sets_NNS that_WDT were_VBD decreased_VBN as_IN the_DT
          target_NN sequence_NN is_VBZ moved_VBN farther_RBR from_IN the_DT 3_CD '_POS end_NN (_( Figure_NN
          4_LS )_) ._.
          Both_DT sets_NNS of_IN amplified_VBN samples_NNS were_VBD affected_VBN in_IN the_DT
          same_JJ manner_NN by_IN this_DT 5_CD '_POS truncation_NN ._. The_DT decreases_NNS seen_VBN
          when_WRB comparing_VBG the_DT 0_CD ._. 1_CD μg_NN to_TO the_DT 0_CD ._. 5_CD μg_NN samples_NNS were_VBD not_RB
          associated_VBN with_IN distance_NN from_IN the_DT 3_CD '_POS end_NN and_CC were_VBD not_RB
          consistent_JJ for_IN particular_JJ probe_NN sets_NNS (_( only_RB 26_CD probe_NN sets_NNS
          decreased_VBD in_IN at_IN least_JJS 7_CD of_IN the_DT 8_CD samples_NNS )_) ._. This_DT indicates_VBZ
          that_IN the_DT truncation_NN is_VBZ a_DT result_NN of_IN the_DT single_JJ cycle_NN of_IN
          amplification_NN ,_, rather_RB than_IN the_DT amount_NN of_IN starting_VBG
          material_NN ._.
        
        
          Ability_NNP to_TO detect_VB differences_NNS in_IN expression_NN between_IN
          treatment_NN groups_NNS
          The_DT main_JJ goal_NN in_IN an_DT experiment_NN comparing_VBG two_CD treatment_NN
          groups_NNS is_VBZ to_TO find_VB genes_NNS whose_WP$ expression_NN differs_VBZ
          significantly_RB ._. To_TO assess_VB whether_IN the_DT lower_JJR starting_VBG
          amounts_NNS of_IN total_JJ RNA_NNP can_MD be_VB used_VBN successfully_RB ,_, a_DT
          comparison_NN of_IN results_NNS from_IN standard_JJ t-tests_JJ was_VBD
          performed_VBN ._. Based_VBN upon_IN the_DT data_NNS in_IN Figure_NN 1_CD ,_, we_PRP filter_NN out_RP
          those_DT probe_NN sets_NNS that_WDT are_VBP not_RB detected_VBN in_IN at_IN least_JJS one_CD of_IN
          the_DT treatment_NN groups_NNS to_TO be_VB compared_VBN before_IN performing_VBG
          statistical_JJ comparisons_NNS ._. To_TO be_VB conservative_JJ ,_, we_PRP only_RB
          eliminated_VBD probe_NN sets_NNS that_WDT are_VBP not_RB called_VBN "_'' present_JJ "_'' on_IN at_IN
          least_JJS half_NN of_IN the_DT GeneChips_NNP ®_NN in_IN either_DT of_IN the_DT treatment_NN
          groups_NNS (_( rather_RB than_IN demand_NN that_IN a_DT probe_NN set_VBN be_VB present_JJ in_IN
          all_DT of_IN the_DT GeneChips_NNP ®_NN in_IN a_DT set_VBN ;_: others_NNS can_MD choose_VB
          different_JJ fractions_NNS )_) ,_, and_CC call_VB this_DT a_DT "_'' detection_NN filter_NN ._. "_''
          This_DT does_VBZ not_RB eliminate_VB probe_NN sets_NNS that_WDT are_VBP either_DT turned_VBN
          on_IN or_CC off_RP ,_, because_IN these_DT would_MD be_VB present_JJ in_IN one_CD of_IN the_DT
          two_CD treatment_NN groups_NNS ._.
          Table_NNP 7_CD gives_VBZ the_DT number_NN of_IN probe_NN sets_NNS that_WDT met_VBD our_PRP$
          criteria_NNS for_IN significance_NN :_: they_PRP passed_VBD the_DT "_'' detection_NN
          filter_NN "_'' and_CC were_VBD significant_JJ at_IN p_NN ≤_NN 0_CD ._. 01_CD for_IN the_DT t-test_JJ
          or_CC at_IN the_DT appropriate_JJ level_NN for_IN the_DT Wilcoxon_NNP rank_NN sum_NN
          test_NN (_( non-parametric_JJ )_) [_NN 13_CD ]_NN ;_: both_DT tests_NNS give_VBP generally_RB
          parallel_JJ results_NNS ._. Even_RB though_IN both_DT the_DT 0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN
          comparisons_NNS are_VBP 4_CD ×_NN 4_CD comparisons_NNS ,_, there_EX is_VBZ a_DT 50_CD %_NN drop_NN in_IN
          the_DT number_NN of_IN significant_JJ probe_NN sets_NNS as_IN compared_VBN to_TO the_DT
          10_CD μg_NN samples_NNS ._. Only_RB part_NN of_IN this_DT drop_NN can_MD be_VB attributed_VBN
          to_TO the_DT decrease_NN in_IN the_DT percent_NN of_IN probe_NN sets_NNS that_WDT met_VBD the_DT
          "_'' detection_NN filter_NN "_'' for_IN these_DT samples_NNS (_( Table_NNP 7_CD )_) ;_: the_DT extra_JJ
          noise_NN introduced_VBN by_IN the_DT amplification_NN ,_, as_IN seen_VBN in_IN the_DT 0_CD ._. 5_CD
          μg_NN group_NN (_( cf_NN ._. Figure_NN 2_CD ,_, Tables_NNP 4_CD and_CC 5_LS )_) ,_, contributes_VBZ
          substantially_RB ,_, since_IN the_DT t-test_JJ is_VBZ sensitive_JJ to_TO increases_NNS
          in_IN standard_JJ deviations_NNS of_IN the_DT two_CD groups_NNS being_VBG
          tested_VBN ._.
          Because_IN of_IN the_DT loss_NN of_IN two_CD of_IN the_DT 2_CD μg_NN arrays_NNS ,_, the_DT
          table_NN also_RB contains_VBZ data_NNS for_IN the_DT subset_NN of_IN six_CD that_WDT match_VBP
          the_DT six_CD remaining_VBG 2_CD μg_NN arrays_NNS ._. Note_VB the_DT sharp_JJ decline_NN in_IN
          the_DT number_NN of_IN probe_NN sets_NNS meeting_VBG the_DT p_NN ≤_NN 0_CD ._. 01_CD
          significance_NN criteria_NNS (_( t-test_JJ )_) when_WRB the_DT number_NN of_IN samples_NNS
          in_IN the_DT 10_CD μg_NN class_NN is_VBZ reduced_VBN from_IN a_DT 4_CD ×_NN 4_CD comparison_NN to_TO
          a_DT 3_CD ×_NN 3_CD comparison_NN (_( Table_NNP 7_CD )_) ;_: this_DT attests_VBZ to_TO the_DT
          additional_JJ power_NN gained_VBN by_IN using_VBG the_DT additional_JJ array_NN ._.
          The_DT best_JJS (_( lowest_JJS )_) p-value_JJ that_WDT can_MD be_VB achieved_VBN in_IN the_DT
          Wilcoxon_NNP test_NN with_IN four_CD samples_NNS for_IN each_DT treatment_NN group_NN
          is_VBZ 0_CD ._. 0143_CD ;_: for_IN three_CD samples_NNS per_IN group_NN it_PRP is_VBZ 0_CD ._. 05_CD [_NN 13_CD ]_NN
          ._. The_DT 2_CD μg_NN samples_NNS also_RB produced_VBD a_DT similar_JJ number_NN of_IN
          significant_JJ probe_NN sets_NNS for_IN the_DT Wilcoxon_NNP with_IN a_DT 0_CD ._. 05_CD
          p-value_JJ as_IN the_DT 10_CD μg_NN samples_NNS with_IN the_DT same_JJ number_NN of_IN
          arrays_NNS ,_, 585_CD for_IN the_DT 2_CD μg_NN samples_NNS and_CC 620_CD for_IN the_DT
          corresponding_JJ 10_CD μg_NN samples_NNS ._. These_DT numbers_NNS can_MD be_VB
          compared_VBN to_TO the_DT 869_CD found_VBD in_IN the_DT complete_JJ set_NN of_IN 10_CD μg_NN
          samples_NNS (_( sample_NN size_NN of_IN 4_LS )_) with_IN a_DT p-value_JJ of_IN 0_CD ._. 0571_CD for_IN
          the_DT Wilcoxon_NNP ._.
          As_IN expected_VBN ,_, probe_NN sets_NNS with_IN low_JJ expression_NN level_NN (_( low_JJ
          signal_NN )_) were_VBD less_RBR reproducible_JJ in_IN comparisons_NNS between_IN the_DT
          different_JJ sample_NN groups_NNS ,_, as_IN were_VBD probe_NN sets_NNS with_IN very_RB low_JJ
          fold-changes_JJ ._. Reproducibility_NNP for_IN the_DT 2_CD μg_NN samples_NNS was_VBD
          best_JJS for_IN probe_NN sets_NNS with_IN a_DT fold_VB change_NN ≥_NN 1_CD ._. 7_CD (_( log_VB 
          2_CD ratio_NN ≥_NN 0_CD ._. 75_CD )_) ._. For_IN the_DT amplified_VBN
          samples_NNS ,_, good_JJ reproducibility_NN was_VBD achieved_VBN for_IN probe_NN sets_NNS
          with_IN fold_VB changes_NNS ≥_NN 2_CD (_( log_VB 
          2_CD ratio_NN ≥_NN 1_LS )_) ._. Calculated_VBN fold_VB changes_NNS
          for_IN the_DT concordant_NN probe_NN sets_NNS were_VBD reasonably_RB stable_JJ
          across_IN the_DT different_JJ groups_NNS ._.
        
        
          Estimate_NNP of_IN technical_JJ false_JJ positive_JJ rate_NN
          The_DT 2_CD μg_NN and_CC 10_CD μg_NN groups_NNS were_VBD from_IN the_DT same_JJ original_JJ
          RNA_NNP extractions_NNS and_CC were_VBD labeled_VBN by_IN the_DT same_JJ protocol_NN ._.
          Because_IN they_PRP were_VBD so_RB comparable_JJ in_IN all_DT of_IN our_PRP$ measures_NNS ,_,
          these_DT 2_CD groups_NNS were_VBD used_VBN to_TO estimate_VB the_DT number_NN of_IN false_JJ
          positives_NNS due_JJ to_TO technical_JJ variability_NN to_TO be_VB expected_VBN
          using_VBG our_PRP$ standard_JJ t-tests_JJ ._. The_DT three_CD 2_CD μg_NN samples_NNS from_IN
          the_DT normal_JJ diet_NN animals_NNS were_VBD compared_VBN to_TO the_DT three_CD 10_CD μg_NN
          samples_NNS from_IN the_DT same_JJ animals_NNS using_VBG the_DT t-test_JJ ,_, and_CC the_DT
          three_CD 2_CD μg_NN samples_NNS from_IN the_DT diet_NN deficient_NN animals_NNS were_VBD
          similarly_RB compared_VBN to_TO the_DT 10_CD μg_NN samples_NNS from_IN the_DT same_JJ
          animals_NNS ._. Since_IN both_DT of_IN these_DT comparisons_NNS are_VBP between_IN
          samples_NNS from_IN the_DT same_JJ set_NN of_IN similarly_RB treated_VBN animals_NNS ,_,
          one_PRP should_MD expect_VB no_DT changes_NNS ._. Therefore_RB ,_, any_DT probe_NN sets_NNS
          that_WDT were_VBD found_VBN to_TO be_VB significantly_RB different_JJ between_IN the_DT
          2_CD μg_NN and_CC 10_CD μg_NN samples_NNS from_IN the_DT same_JJ animals_NNS would_MD be_VB
          false_JJ positives_NNS ._. For_IN each_DT comparison_NN ,_, normal_JJ and_CC
          deficient_NN ,_, 14_CD probe_NN sets_NNS were_VBD found_VBN to_TO be_VB significantly_RB
          different_JJ between_IN the_DT 2_CD μg_NN and_CC 10_CD μg_NN samples_NNS ,_, which_WDT is_VBZ a_DT
          false_JJ positive_JJ rate_NN of_IN 0_CD ._. 4_CD %_NN of_IN the_DT probe_NN sets_NNS that_WDT met_VBD
          the_DT "_'' detection_NN filter_NN ._. "_'' Of_IN these_DT 28_CD ,_, only_RB 3_CD of_IN the_DT normal_JJ
          group_NN and_CC 4_CD of_IN the_DT deficient_NN group_NN had_VBD a_DT fold-change_JJ
          greater_JJR than_IN 1_CD ._. 5_CD and_CC only_RB one_CD in_IN each_DT group_NN had_VBD a_DT
          fold-change_JJ that_WDT exceeded_VBD 2_CD ._. Fold-changes_NNP larger_JJR than_IN 1_CD ._. 5_CD
          were_VBD seen_VBN only_RB in_IN probe_NN sets_NNS with_IN average_JJ signals_NNS <_NN
          900_CD ._. Those_DT probe_NN sets_NNS with_IN signals_NNS over_IN 900_CD had_VBD smaller_JJR
          fold_VB changes_NNS ,_, most_JJS less_JJR than_IN 1_CD ._. 3_CD ._.
          In_IN comparison_NN ,_, for_IN those_DT probe_NN sets_NNS that_WDT did_VBD not_RB meet_VB
          the_DT "_'' detection_NN filter_NN "_'' ,_, the_DT false_JJ positive_JJ rate_NN was_VBD
          approximately_RB 1_CD %_NN at_IN a_DT p-value_JJ of_IN 0_CD ._. 01_CD ._. This_DT set_NN of_IN false_JJ
          positives_NNS was_VBD equally_RB balanced_JJ between_IN increases_NNS and_CC
          decreases_NNS (_( 53_CD increases_NNS and_CC 58_CD decreases_NNS in_IN the_DT two_CD
          treatment_NN groups_NNS )_) ,_, indicating_VBG random_JJ noise_NN and_CC not_RB an_DT
          effect_NN of_IN using_VBG 2_CD μg_NN instead_RB of_IN 10_CD μg_NN of_IN RNA_NNP ._. The_DT fold_VB
          changes_NNS ranged_VBD from_IN 1_CD ._. 2_CD to_TO 12_CD ._. 5_LS ._. The_DT large_JJ fold_VB changes_NNS
          result_VBP from_IN very_RB small_JJ denominators_NNS used_VBN in_IN the_DT fold_VB
          change_NN calculations_NNS for_IN these_DT probe_NN sets_NNS ._.
        
      
      
        Discussion_NNP
        This_DT experiment_NN demonstrated_VBN that_IN technical_JJ variability_NN
        is_VBZ much_RB smaller_JJR than_IN biological_JJ variation_NN when_WRB using_VBG the_DT
        standard_JJ protocol_NN ._. The_DT number_NN of_IN differences_NNS between_IN
        samples_NNS from_IN the_DT same_JJ animal_NN that_WDT resulted_VBD from_IN using_VBG the_DT
        lower_JJR amount_NN of_IN starting_VBG material_NN was_VBD much_RB smaller_JJR than_IN the_DT
        biological_JJ variation_NN between_IN animals_NNS treated_VBD the_DT same_JJ and_CC
        labeled_VBN by_IN the_DT standard_JJ protocol_NN ._. The_DT standard_JJ protocol_NN
        worked_VBD well_RB with_IN samples_NNS as_RB small_JJ as_IN 2_CD μg_NN ,_, producing_VBG
        results_NNS very_RB similar_JJ to_TO those_DT of_IN the_DT 10_CD μg_NN sample_NN from_IN the_DT
        same_JJ animal_NN ._. Although_IN in_IN this_DT experiment_NN ,_, starting_VBG with_IN
        less_JJR than_IN 1_CD μg_NN of_IN total_JJ RNA_NNP did_VBD not_RB produce_VB enough_RB
        biotinylated_JJ cRNA_NN for_IN hybridization_NN under_IN the_DT normal_JJ
        protocol_NN ,_, a_DT minor_JJ change_NN (_( using_VBG vacuum_NN evaporation_NN to_TO
        concentrate_VB samples_NNS before_IN cRNA_NN synthesis_NN ,_, and_CC mixing_VBG the_DT
        minimum_JJ 200_CD μl_NN hybridization_NN volume_NN )_) should_MD allow_VB use_NN of_IN 1_CD
        μg_NN samples_NNS with_IN the_DT standard_JJ protocol_NN ._. This_DT extends_VBZ the_DT
        range_NN of_IN samples_NNS that_WDT can_MD readily_RB be_VB analyzed_VBN on_IN Affymetrix_NNP
        GeneChips_NNP ®_NN using_VBG the_DT standard_JJ protocol_NN ._.
        We_PRP have_VBP demonstrated_VBN here_RB that_IN a_DT single_JJ cycle_NN of_IN
        amplification_NN sufficed_VBD to_TO produce_VB cRNA_NN from_IN samples_NNS as_RB low_JJ
        as_IN 0_CD ._. 1_CD μg_NN of_IN total_JJ RNA_NNP ._. The_DT amplification_NN protocol_NN uses_VBZ the_DT
        cRNA_NN from_IN the_DT initial_JJ protocol_NN as_IN starting_VBG material_NN for_IN a_DT
        second_JJ round_NN of_IN cDNA_NN synthesis_NN and_CC 
        in_IN vitro_NN transcription_NN ._. We_PRP
        hypothesized_VBN that_IN each_DT round_NN of_IN cDNA_NN synthesis_NN would_MD lead_VB
        to_TO some_DT truncation_NN of_IN the_DT molecules_NNS ,_, due_JJ both_DT to_TO the_DT
        possibility_NN of_IN priming_VBG the_DT second_JJ strand_NN from_IN an_DT internal_JJ
        site_NN and_CC to_TO cleavage_NN of_IN the_DT relatively_RB labile_NN RNA_NNP ._. For_IN this_DT
        reason_NN ,_, we_PRP limited_JJ our_PRP$ amplification_NN to_TO a_DT single_JJ round_NN ,_,
        rather_RB than_IN using_VBG two_CD cycles_NNS as_IN had_VBN previously_RB been_VBN
        reported_VBN [_NN 10_CD ]_NN ._. The_DT hypothesized_VBN shortening_VBG was_VBD observed_VBN :_:
        the_DT cRNA_NN extended_VBN to_TO about_IN 850_CD nt_RB ,_, compared_VBN with_IN about_RB 2000_CD
        nt_RB for_IN the_DT standard_JJ protocol_NN ._. This_DT shortening_VBG was_VBD also_RB
        demonstrated_VBN by_IN differential_NN loss_NN of_IN signal_NN from_IN probe_NN sets_NNS
        further_JJ away_RB from_IN the_DT 3_CD '_POS end_NN of_IN the_DT RNA_NNP ,_, as_IN shown_VBN with_IN the_DT
        Affymetrix_NNP control_NN probe_NN sets_NNS (_( Tables_NNP 1_CD and_CC 6_CD )_) ,_, and_CC by_IN the_DT
        progressive_JJ loss_NN in_IN probe_NN sets_NNS detected_VBD as_IN a_DT function_NN of_IN
        their_PRP$ distance_NN from_IN the_DT 3_CD '_POS end_NN (_( Figure_NN 4_LS )_) ._. The_DT
        amplification_NN systematically_RB affected_VBD over_IN 700_CD probe_NN sets_NNS
        in_IN at_IN least_JJS 7_CD of_IN 8_CD samples_NNS for_IN both_DT the_DT 0_CD ._. 1_CD μg_NN and_CC 0_CD ._. 5_CD μg_NN
        groups_NNS ._. Indeed_RB ,_, of_IN the_DT probe_NN sets_NNS with_IN consistent_JJ decreases_NNS
        across_IN the_DT 0_CD ._. 1_CD μg_NN and_CC 0_CD ._. 5_CD μg_NN samples_NNS about_IN 90_CD %_NN have_VBP target_NN
        distances_NNS greater_JJR than_IN 400_CD nucleotides_NNS from_IN the_DT 3_CD '_POS end_NN of_IN
        the_DT measured_VBN transcript_NN ,_, with_IN 26_CD -_: 28_CD %_NN in_IN the_DT 400_CD -_: 600_CD range_NN
        and_CC 60_CD -_: 62_CD %_NN over_IN 600_CD ._. Because_IN the_DT effect_NN of_IN the_DT loss_NN of_IN the_DT
        5_CD '_POS end_NN is_VBZ systematic_JJ ,_, it_PRP renders_NNS a_DT group_NN of_IN probe_NN sets_NNS
        designed_VBN from_IN sequences_NNS further_RB from_IN the_DT 3_CD '_POS end_NN
        undetectable_JJ ._. Therefore_RB ,_, we_PRP recommend_VBP using_VBG the_DT standard_JJ
        protocol_NN instead_RB of_IN using_VBG the_DT amplification_NN strategy_NN for_IN
        samples_NNS down_IN to_TO 1_CD μg_NN of_IN total_JJ RNA_NNP ,_, and_CC our_PRP$ simplified_VBN
        amplification_NN protocol_NN for_IN smaller_JJR samples_NNS ,_, at_IN least_JJS down_IN
        to_TO 0_CD ._. 1_CD μg_NN ._. This_DT extends_VBZ the_DT range_NN of_IN samples_NNS that_WDT can_MD be_VB
        usefully_RB analyzed_VBN by_IN oligonucleotide_NN microarrays_NNS ._. This_DT
        experiment_NN used_VBD the_DT Affymetrix_NNP RGU_NNP 34_CD A_DT GeneChip_NNP ®_NN ,_, which_WDT was_VBD
        designed_VBN using_VBG version_NN 34_CD of_IN Uni_NNP Gene_NNP for_IN the_DT rat_NN ,_, November_NNP
        1998_CD For_IN newer_JJR arrays_NNS such_JJ as_IN the_DT new_JJ human_JJ U_NNP 133_CD GeneChip_NNP
        ®_NN ,_, designed_VBN using_VBG better_RB sequence_NN information_NN and_CC improved_VBN
        probe_NN designs_NNS (_( Affymetrix_NNP technical_JJ report_NN Array_NNP Design_NNP for_IN
        the_DT GeneChip_NNP ®_NN Human_NNP Genome_NNP 133_CD Set_NNP )_) ,_, we_PRP expect_VBP that_IN the_DT
        problem_NN with_IN loss_NN of_IN the_DT 5_CD '_POS end_NN of_IN the_DT transcript_NN ._. will_MD be_VB
        lessened_JJ ,_, but_CC not_RB eliminated_VBN ,_, because_IN the_DT targets_NNS are_VBP more_RBR
        likely_JJ to_TO be_VB near_IN the_DT real_JJ 3_CD '_POS ends_NNS of_IN the_DT mRNAs_NNS The_DT
        truncation_NN that_IN results_NNS from_IN amplifying_VBG samples_NNS means_VBZ that_IN
        the_DT same_JJ protocol_NN should_MD be_VB used_VBN for_IN all_DT samples_NNS in_IN a_DT given_VBN
        study_NN ._.
        New_JJ protocols_NNS that_WDT increase_NN the_DT production_NN of_IN cDNA_NN [_NN 14_CD
        15_CD ]_NN using_VBG primers_NNS attached_VBN to_TO the_DT 5_CD '_POS end_NN of_IN the_DT transcript_NN
        could_MD increase_VB cDNA_NN yields_NNS from_IN small_JJ amounts_NNS of_IN RNA_NNP But_CC
        Iscove_NNP [_NN 14_CD ]_NN states_NNS "_'' only_RB a_DT few_JJ hundred_CD bases_NNS of_IN extreme_JJ
        3_CD '_POS sequence_NN "_'' are_VBP amplified_VBN by_IN their_PRP$ method_NN This_DT procedure_NN
        would_MD be_VB expected_VBN to_TO greatly_RB exacerbate_VB the_DT loss_NN of_IN signal_NN
        due_JJ to_TO shortened_VBN transcripts_NNS ._.
        There_EX was_VBD additional_JJ variation_NN in_IN the_DT amplified_VBN samples_NNS
        (_( Table_NNP 5_LS )_) that_WDT is_VBZ probably_RB due_JJ to_TO the_DT extra_JJ steps_NNS required_VBN
        in_IN the_DT protocol_NN ._. This_DT extra_JJ noise_NN is_VBZ partially_RB responsible_JJ
        for_IN the_DT decrease_NN in_IN the_DT number_NN of_IN probe_NN sets_NNS that_WDT differ_VBP at_IN
        a_DT p-value_JJ ≤_NN 0_CD ._. 01_CD ._. This_DT ,_, coupled_VBN with_IN the_DT decrease_NN in_IN the_DT
        percent_NN of_IN probe_NN sets_NNS present_JJ ,_, reduces_VBZ the_DT ability_NN to_TO find_VB
        transcripts_NNS that_WDT differ_VBP significantly_RB in_IN expression_NN when_WRB
        using_VBG the_DT amplification_NN protocol_NN ._. The_DT problem_NN is_VBZ
        exacerbated_VBN for_IN transcripts_NNS with_IN small_JJ differences_NNS in_IN
        expression_NN (_( low_JJ fold_VB changes_NNS )_) ._. Fold_NNP changes_NNS ≥_NN 2_CD were_VBD much_RB
        more_RBR likely_JJ to_TO be_VB identified_VBN in_IN the_DT amplified_VBN samples_NNS ._. It_PRP
        may_MD be_VB especially_RB helpful_JJ to_TO increase_VB the_DT number_NN of_IN arrays_NNS
        used_VBN in_IN these_DT amplification_NN experiments_NNS to_TO get_VB more_JJR power_NN
        to_TO detect_VB changes_NNS
        Our_PRP$ experiment_NN also_RB provided_VBD a_DT false_JJ positive_JJ estimate_NN
        of_IN technical_JJ variability_NN for_IN the_DT t-test_JJ with_IN 14_CD found_VBD in_IN
        each_DT treatment_NN group_NN when_WRB comparing_VBG the_DT 10_CD μg_NN samples_NNS to_TO
        the_DT 2_CD μg_NN samples_NNS (_( 0_CD ._. 4_LS %_NN of_IN the_DT present_JJ probe_NN sets_NNS ._. )_) ._. These_DT
        false_JJ positives_NNS came_VBD disproportionately_RB from_IN the_DT genes_NNS
        expressed_VBD at_IN lower_JJR levels_NNS ._. Genes_NNP expressed_VBD at_IN these_DT low_JJ
        levels_NNS often_RB show_VBP high_JJ fold-changes_JJ because_IN the_DT denominator_NN
        is_VBZ so_RB low_JJ (_( often_RB near_IN background_NN )_) ,_, this_DT points_NNS out_RP the_DT
        danger_NN in_IN emphasizing_VBG high_JJ fold-changes_JJ ,_, rather_RB than_IN
        reproducible_JJ changes_NNS ._. Therefore_RB ,_, for_IN genes_NNS expressed_VBD at_IN
        lower_JJR levels_NNS ,_, it_PRP might_MD be_VB reasonable_JJ to_TO use_VB a_DT more_RBR
        restrictive_JJ p-value_JJ ,_, none_NN of_IN the_DT false_JJ positives_NNS had_VBD a_DT
        p-value_JJ less_JJR than_IN 0_CD ._. 001_CD ._. Restricting_NNP probe_NN sets_NNS to_TO those_DT
        minimally_RB present_JJ (_( our_PRP$ "_'' detection_NN filter_NN "_'' )_) dramatically_RB
        decreases_VBZ the_DT number_NN of_IN false_JJ positives_NNS ,_, from_IN an_DT average_NN of_IN
        56_CD down_IN to_TO 14_CD ,_, restricting_VBG analysis_NN to_TO genes_NNS called_VBD present_JJ
        in_IN a_DT higher_JJR fraction_NN of_IN the_DT arrays_NNS from_IN one_CD of_IN the_DT
        comparison_NN groups_NNS could_MD further_RB reduce_VB false_JJ positives_NNS ,_, but_CC
        at_IN the_DT cost_NN of_IN missing_VBG some_DT true_JJ positives_NNS ._. The_DT tradeoff_NN
        can_MD be_VB chosen_VBN by_IN an_DT investigator_NN based_VBN upon_IN the_DT relative_JJ
        cost_NN of_IN false_JJ positives_NNS and_CC value_NN of_IN detecting_VBG differences_NNS
        in_IN genes_NNS expressed_VBD at_IN low_JJ levels_NNS ._.
        The_DT statistical_JJ power_NN to_TO detect_VB differences_NNS was_VBD much_RB
        reduced_VBN when_WRB 3_CD samples_NNS per_IN group_NN were_VBD analyzed_VBN instead_RB of_IN
        4_CD ._. The_DT 2_CD μg_NN samples_NNS and_CC the_DT matched_VBN 10_CD μg_NN samples_NNS were_VBD able_JJ
        to_TO detect_VB 83_CD -_: 86_CD differences_NNS at_IN p_NN ≤_NN 0_CD ._. 01_CD as_IN compared_VBN to_TO 150_CD
        differences_NNS when_WRB using_VBG all_DT of_IN the_DT 10_CD μg_NN samples_NNS ._. This_DT
        decrease_NN was_VBD expected_VBN ,_, but_CC illustrates_VBZ that_IN a_DT 25_CD %_NN decrease_NN
        in_IN expense_NN may_MD result_VB in_IN a_DT much_RB greater_JJR loss_NN of_IN
        information_NN ._.
      
      
        Conclusions_NNP
        This_DT experiment_NN explored_JJ the_DT effects_NNS of_IN using_VBG less_JJR than_IN
        the_DT standard_JJ 10_CD μg_NN of_IN total_JJ RNA_NNP for_IN an_DT Affymetnx_NNP GeneChip_NNP
        ®_NN experiment_NN ,_, and_CC examined_VBD how_WRB biological_JJ and_CC technical_JJ
        variation_NN affect_VBP the_DT ability_NN to_TO detect_VB biological_JJ
        differences_NNS in_IN a_DT typical_JJ experiment_NN comparing_VBG gene_NN
        expression_NN in_IN two_CD conditions_NNS ._. The_DT overall_JJ conclusions_NNS are_VBP
        that_IN (_( 1_LS )_) small_JJ amounts_NNS of_IN RNA_NNP can_MD be_VB used_VBN effectively_RB in_IN
        the_DT standard_JJ protocol_NN ,_, (_( 2_LS )_) even_RB very_RB small_JJ amounts_NNS of_IN RNA_NNP
        (_( 0_CD ._. 1_LS μg_NN )_) can_MD be_VB used_VBN with_IN our_PRP$ simplified_VBN amplification_NN
        protocol_NN to_TO detect_VB differential_NN gene_NN expression_NN ,_, (_( 3_LS )_)
        biological_JJ variation_NN is_VBZ larger_JJR than_IN technical_JJ variation_NN ,_,
        (_( 4_LS )_) very_RB low-level_JJ signals_NNS are_VBP prone_JJ to_TO false_JJ positives_NNS and_CC
        to_TO less_RBR reliable_JJ fold-changes_JJ ,_, false_JJ positives_NNS can_MD be_VB
        reduced_VBN by_IN filtering_VBG out_IN probe_NN sets_NNS not_RB reliably_RB detected_VBD
        before_IN statistical_JJ comparisons_NNS ,_, and_CC (_( 5_LS )_) using_VBG 4_CD independent_JJ
        biological_JJ samples_NNS is_VBZ much_RB better_JJR than_IN using_VBG 3_CD samples_NNS in_IN
        allowing_VBG detection_NN of_IN consistent_JJ changes_NNS and_CC reducing_VBG false_JJ
        positives_NNS ._.
      
      
        Methods_NNP
        
          Labeling_VBG test_NN
          Total_NNP RNA_NNP was_VBD extracted_VBN from_IN the_DT livers_NNS of_IN 4_CD rats_NNS fed_VBD
          a_DT normal_JJ diet_NN (_( untreated_JJ )_) and_CC 4_CD fed_VBD a_DT vitamin-deficient_JJ
          diet_NN (_( treated_VBN )_) using_VBG the_DT RNeasy_NNP ®_NN kit_NN (_( Qiagen_NNP Inc_NNP ,_,
          Valencia_NNP ,_, CA_NNP )_) ._. The_DT RNA_NNP was_VBD resuspended_JJ and_CC re-extracted_JJ
          using_VBG the_DT same_JJ protocol_NN ,_, to_TO reduce_VB DNA_NNP contamination_NN ._. For_IN
          the_DT labeling_VBG test_NN ,_, two_CD pools_NNS were_VBD created_VBN ,_, one_CD treated_VBN
          and_CC one_CD untreated_JJ ,_, by_IN mixing_VBG equal_JJ aliquots_NNS from_IN each_DT of_IN
          the_DT 4_CD RNA_NNP samples_NNS ._. The_DT final_JJ concentration_NN was_VBD adjusted_VBN
          to_TO 1_CD μg_NN /_NN 2_CD μl_NN ,_, and_CC each_DT pool_NN was_VBD divided_VBN into_IN 4_CD aliquots_NNS
          of_IN 1_CD μg_NN each_DT ._. These_DT pooled_VBN samples_NNS were_VBD used_VBN to_TO determine_VB
          the_DT average_JJ cRNA_NN yield_NN from_IN 1_CD μg_NN of_IN total_JJ RNA_NNP and_CC to_TO
          compare_VB the_DT yields_NNS of_IN the_DT T_NN 7_CD polymerases_NNS from_IN two_CD
          different_JJ 
          in_IN vitro_NN transcription_NN kits_NNS ._.
          Biotinylated_NNP cRNA_NN was_VBD prepared_VBN using_VBG the_DT standard_JJ
          Affymetrix_NNP protocol_NN [_NN 8_CD ]_NN except_IN that_IN the_DT Epicentre_NNP
          AmpliScribe_NNP ™_NN T_NN 7_CD polymerase_NN (_( Epicentre_NNP ,_, Madison_NNP ,_, WI_NNP )_) was_VBD
          substituted_VBN for_IN the_DT ENZO_NNP T_NN 7_CD polymerase_NN (_( BioArray_NNP ,_, High_NNP
          Yield_NNP RNA_NNP Transcript_NNP Labeling_VBG Kit_NNP ,_, ENZO_NNP Diagnostics_NNPS ,_,
          Inc_NNP ._. ,_, Farmingdale_NNP ,_, NY_NNP )_) for_IN 2_CD of_IN the_DT treated_VBN and_CC 2_CD of_IN the_DT
          untreated_JJ pooled_VBN samples_NNS ._. The_DT yield_NN of_IN cRNA_NN was_VBD estimated_VBN
          from_IN absorbance_NN at_IN 260_CD nm_NN ,_, using_VBG an_DT Amersham_NNP Pharmacia_NNP
          Biotech_NNP Ultrospec_NNP 3100_CD pro_FW spectrophotometer_NN ._. This_DT part_NN
          of_IN the_DT experiment_NN was_VBD the_DT only_JJ time_NN RNAs_NNP from_IN different_JJ
          animals_NNS were_VBD pooled_VBN ,_, the_DT cRNAs_NNS from_IN these_DT pooled_VBN samples_NNS
          were_VBD not_RB hybridized_JJ to_TO arrays_NNS ._.
        
        
          Labeling_VBG for_IN microarrays_NNS
          Aliquots_NNP of_IN each_DT of_IN the_DT original_JJ 8_CD samples_NNS of_IN total_JJ
          RNA_NNP (_( one_CD from_IN each_DT rat_NN )_) were_VBD treated_VBN as_IN individual_JJ
          samples_NNS for_IN all_DT hybridization_NN experiments_NNS ._. Each_DT sample_NN
          was_VBD serially_RB diluted_VBN to_TO yield_VB 10_CD μl_NN samples_NNS containing_VBG 10_CD
          μg_NN ,_, 2_CD μg_NN ,_, 0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN total_JJ RNA_NNP (_( 32_CD samples_NNS )_) ._. For_IN
          the_DT 10_CD μg_NN and_CC 2_CD μg_NN samples_NNS ,_, cRNA_NN was_VBD prepared_VBN using_VBG the_DT
          standard_JJ Affymetrix_NNP protocol_NN [_NN 8_CD ]_NN ._. We_PRP made_VBD slight_JJ
          modifications_NNS for_IN the_DT 2_CD μg_NN samples_NNS to_TO increase_VB the_DT
          concentration_NN by_IN decreasing_VBG added_VBN water_NN where_WRB that_WDT was_VBD
          possible_JJ ._. Because_IN the_DT cRNA_NN yield_NN from_IN the_DT 1_CD μg_NN pooled_VBN
          sample_NN test_NN was_VBD low_JJ ,_, we_PRP decided_VBD to_TO amplify_VB the_DT smaller_JJR
          samples_NNS ._. The_DT 0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN samples_NNS were_VBD amplified_VBN by_IN
          a_DT modification_NN of_IN the_DT protocol_NN of_IN Ohyama_NNP et_CC al_NN ._. [_NN 10_CD ]_NN ,_,
          using_VBG only_RB a_DT single_JJ round_NN of_IN amplification_NN ._. In_IN short_JJ ,_,
          double-stranded_JJ cDNA_NN was_VBD synthesized_JJ from_IN the_DT total_JJ RNA_NNP
          using_VBG the_DT SuperScript_NNP II_NNP kit_NN from_IN Invitrogen_NNP and_CC the_DT
          Affymetrix_NNP T_NN 7_CD -_: (_( dT_NN )_) 
          24_CD primer_NN ,_, which_WDT contains_VBZ a_DT T_NN 7_CD
          promoter_NN attached_VBN to_TO a_DT poly-d_JJ T_NN sequence_NN
          5_CD '_POS -_: GGCCAGTGAATTGTAATACGACTCACTATAGGGAGGCGG-_NNP (_( dT_NN )_) 
          24_CD -_: 3_CD '_'' ._. The_DT Epicentre_NNP AmpliScribe_NNP T_NN 7_CD
          High_NNP Yield_NNP Transcription_NNP kit_NN was_VBD used_VBN to_TO produce_VB
          unlabeled_JJ cRNA_NN by_IN 
          in_IN vitro_NN transcription_NN with_IN
          unbiotinylated_JJ NTPs_NNP ._. This_DT 
          in_IN vitro_NN transcription_NN step_NN was_VBD
          followed_VBN by_IN a_DT second_JJ round_NN of_IN double-stranded_JJ cDNA_NN
          synthesis_NN ,_, and_CC finally_RB by_IN 
          in_IN vitro_NN transcription_NN using_VBG the_DT T_NN 7_CD
          RNA_NNP polymerase_NN with_IN the_DT Enzo_NNP BioArray_NNP ,_, High_NNP Yield_NNP RNA_NNP
          Transcript_NNP Labeling_VBG Kit_NNP with_IN biotinylated_JJ NTPs_NNP in_IN the_DT
          usual_JJ manner_NN ._. Yields_NNS of_IN cDNA_NN and_CC cRNA_NN were_VBD measured_VBN using_VBG
          an_DT Amersham_NNP Pharmacia_NNP Biotech_NNP Ultrospec_NNP 3100_CD pro_FW
          spectrophotometer_NN in_IN order_NN to_TO adjust_VB concentrations_NNS for_IN
          subsequent_JJ steps_NNS ._. Measurements_NNP of_IN the_DT amplified_VBN samples_NNS
          were_VBD made_VBN after_IN the_DT second_JJ round_NN of_IN cDNA_NN synthesis_NN and_CC 
          in_IN vitro_NN transcription_NN ,_, to_TO limit_VB
          the_DT loss_NN of_IN sample_NN ._. After_IN the_DT final_JJ round_NN of_IN cRNA_NN
          synthesis_NN ,_, aliquots_NNS of_IN biotinylated_JJ cRNA_NN from_IN each_DT sample_NN
          were_VBD electrophoresed_JJ on_IN 1_CD %_NN agarose_NN gels_NNS in_IN TBE_NNP buffer_NN to_TO
          check_VB them_PRP for_IN quality_NN and_CC length_NN ,_, the_DT buffer_NN and_CC gel_NN
          both_DT contained_VBD a_DT 500_CD ng_NN /_NN ml_NN concentration_NN of_IN ethidium_NN
          bromide_NN ._. The_DT Invitrogen_NNP 1_CD Kb_NNP Plus_NNP DNA_NNP ladder_NN was_VBD used_VBN to_TO
          provide_VB a_DT relative_JJ measure_NN of_IN length_NN ._.
          Since_IN it_PRP was_VBD not_RB feasible_JJ to_TO label_VB this_DT many_JJ samples_NNS
          at_IN one_CD time_NN ,_, a_DT balanced_JJ experimental_JJ design_NN was_VBD used_VBN
          processing_NN groups_NNS of_IN 10_CD μg_NN and_CC 2_CD μg_NN samples_NNS for_IN the_DT same_JJ
          animal_NN together_RB and_CC always_RB labeling_VBG an_DT equal_JJ number_NN of_IN
          normal_JJ and_CC vitamin-deficient_JJ samples_NNS at_IN one_CD time_NN ._. For_IN the_DT
          amplification_NN protocol_NN ,_, 0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN samples_NNS from_IN
          the_DT same_JJ animal_NN were_VBD processed_VBN together_RB for_IN each_DT step_NN ,_,
          again_RB with_IN balanced_JJ numbers_NNS of_IN normal_JJ and_CC vitamin_NN
          deficient_NN samples_NNS processed_VBN together_RB ._.
        
        
          Array_NNP hybridization_NN
          Each_DT sample_NN was_VBD hybridized_JJ to_TO a_DT separate_JJ Affymetrix_NNP
          RGU_NNP 34_CD A_DT GeneChip_NNP ®_NN ._. For_IN most_JJS samples_NNS ,_, hybridization_NN
          cocktails_NNS of_IN 300_CD μl_NN contained_VBD 15_CD μg_NN of_IN fragmented_JJ cRNA_NN ,_,
          200_CD μl_NN of_IN the_DT cocktail_NN were_VBD injected_VBN into_IN the_DT GeneChip_NNP
          ®_NN for_IN hybridization_NN ._. One_CD 2_CD μg_NN sample_NN had_VBD a_DT lower_JJR yield_NN so_IN
          a_DT 200_CD μl_NN hybridization_NN cocktail_NN containing_VBG 10_CD μg_NN of_IN cRNA_NN
          was_VBD made_VBN ,_, to_TO keep_VB the_DT concentration_NN fixed_VBN ._. For_IN the_DT 0_CD ._. 1_CD μg_NN
          samples_NNS ,_, the_DT cRNA_NN yield_NN was_VBD less_JJR than_IN 15_CD μg_NN so_RB 5_CD -_: 7_CD 5_CD μg_NN
          of_IN cRNA_NN was_VBD used_VBN for_IN the_DT hybridization_NN cocktail_NN ._. Data_NNS
          from_IN two_CD of_IN the_DT 2_CD μg_NN GeneChips_NNP ®_NN (_( 1_CD from_IN each_DT treatment_NN
          group_NN )_) and_CC their_PRP$ hybridization_NN cocktail_NN were_VBD unusable_JJ due_NN
          to_TO a_DT bad_JJ lot_NN of_IN BSA_NNP (_( used_VBN as_IN a_DT blocking_VBG factor_NN during_IN
          hybridization_NN )_) ._. The_DT analyses_NNS for_IN the_DT 2_CD μg_NN group_NN were_VBD
          completed_VBN using_VBG the_DT remaining_VBG 6_CD GeneChips_NNP ®_NN ._. For_IN some_DT
          comparisons_NNS with_IN this_DT group_NN ,_, only_RB the_DT corresponding_JJ 6_CD
          GeneChips_NNP ®_NN from_IN the_DT 10_CD μg_NN samples_NNS were_VBD used_VBN ._.
        
        
          Scanning_NNP and_CC analysis_NN
          Each_DT GeneChip_NNP ®_NN was_VBD scanned_JJ and_CC analyzed_VBD using_VBG
          Affymetrix_NNP Microarray_NNP Analysis_NNP Suite_NNP (_( MAS_NNP )_) version_NN 5_CD ._. 0_CD [_NN
          11_CD ]_NN ._. Each_DT sample_NN was_VBD scaled_VBN to_TO a_DT target_NN intensity_NN of_IN
          1000_CD using_VBG the_DT "_'' all_DT probe_NN sets_NNS "_'' scaling_VBG option_NN ,_, this_DT
          option_NN scales_NNS the_DT trimmed_VBD mean_NN target_NN intensity_NN to_TO the_DT
          specified_VBN value_NN [_NN 11_CD ]_NN ._. The_DT Affymetrix_NNP MAS_NNP 5_CD expression_NN
          report_NN provides_VBZ statistics_NNS for_IN each_DT chip_NN that_WDT can_MD be_VB used_VBN
          for_IN quality_NN control_NN purposes_NNS ._. Included_VBN in_IN this_DT report_NN are_VBP
          noise_NN ,_, background_NN ,_, the_DT percent_NN of_IN probe_NN sets_NNS called_VBN
          present_JJ ,_, the_DT scaling_VBG factor_NN calculated_VBN by_IN the_DT absolute_JJ
          analysis_NN algorithm_NN and_CC the_DT ratio_NN of_IN 3_CD '_POS to_TO 5_CD '_POS signal_NN for_IN
          GAPDH_NNP and_CC β-actin_JJ ._. These_DT measures_NNS were_VBD used_VBN to_TO judge_VB the_DT
          quality_NN and_CC similarity_NN of_IN data_NNS from_IN the_DT various_JJ RNA_NNP
          sample_NN size_NN groups_NNS ._.
          MAS_NNP 5_CD "_'' absolute_JJ "_'' and_CC "_'' comparison_NN "_'' expression_NN analyses_NNS
          were_VBD performed_VBN [_NN 11_CD ]_NN ._. The_DT RGU_NNP 34_CD A_DT chip_NN contains_VBZ 8799_CD
          probe_NN sets_NNS (_( series_NN of_IN probe_NN pairs_NNS that_WDT query_NN parts_NNS of_IN the_DT
          same_JJ gene_NN or_CC EST_NNP )_) [_NN 7_CD ]_NN ._. For_IN each_DT probe_NN set_VBD ,_, absolute_JJ
          analysis_NN generates_VBZ a_DT signal_NN value_NN (_( expression_NN level_NN )_) ,_, a_DT
          detection_NN call_NN of_IN absent_JJ ,_, present_JJ ,_, or_CC marginal_JJ ,_, and_CC a_DT
          p-value_JJ associated_VBN with_IN the_DT detection_NN call_NN [_NN 11_CD ]_NN ._.
          Comparison_NNP analysis_NN examines_VBZ 2_CD GeneChips_NNP ®_NN and_CC indicates_VBZ
          for_IN each_DT probe_NN set_VBN whether_IN there_EX is_VBZ a_DT significant_JJ
          difference_NN in_IN the_DT signal_NN between_IN the_DT two_CD arrays_NNS ._. The_DT
          output_NN is_VBZ a_DT change_NN call_NN of_IN increase_NN ,_, marginal_JJ increase_NN ,_,
          decrease_VB ,_, marginal_JJ decrease_NN or_CC no_DT change_NN ,_, a_DT p-value_JJ
          associated_VBN with_IN the_DT change_NN call_NN ,_, and_CC the_DT magnitude_NN of_IN the_DT
          difference_NN (_( as_IN the_DT signal_NN log_NN ratio_NN ,_, the_DT log_NN 
          2_CD (_( log_VB base_NN 2_LS )_) ratio_NN of_IN the_DT signal_NN
          from_IN first_JJ chip_NN to_TO the_DT signal_NN on_IN the_DT second_NN or_CC baseline_NN
          chip_NN )_) ._. Comparisons_NNP were_VBD made_VBN between_IN the_DT
          vitamin-deficient_JJ and_CC normal_JJ diet_NN animals_NNS in_IN each_DT sample_NN
          size_NN group_NN using_VBG the_DT normal_JJ diet_NN samples_NNS as_IN the_DT baseline_NN
          for_IN each_DT comparison_NN ._. All_DT possible_JJ comparisons_NNS were_VBD made_VBN ,_,
          this_DT equaled_VBD 16_CD comparisons_NNS each_DT (_( 4_CD ×_NN 4_LS )_) for_IN the_DT 10_CD μg_NN ,_,
          0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN groups_NNS and_CC 9_CD comparisons_NNS for_IN the_DT 2_CD μg_NN
          samples_NNS ._. Comparisons_NNP were_VBD also_RB made_VBN between_IN each_DT of_IN the_DT 2_CD
          μg_NN ,_, 0_CD ._. 5_CD μg_NN and_CC 0_CD ._. 1_CD μg_NN samples_NNS and_CC the_DT 10_CD μg_NN sample_NN from_IN
          the_DT same_JJ animal_NN ,_, to_TO look_VB for_IN apparent_JJ differences_NNS in_IN gene_NN
          expression_NN that_WDT are_VBP really_RB due_JJ to_TO the_DT differences_NNS in_IN the_DT
          amount_NN of_IN starting_VBG material_NN and_CC sample_NN processing_NN ._. For_IN
          these_DT comparisons_NNS ,_, the_DT 10_CD μg_NN sample_NN was_VBD used_VBN as_IN the_DT
          baseline_NN ._.
          In_IN addition_NN ,_, comparisons_NNS were_VBD made_VBN between_IN the_DT 10_CD μg_NN
          arrays_NNS within_IN each_DT treatment_NN group_NN to_TO measure_VB
          variability_NN ,_, both_DT between-animal_JJ and_CC technical_JJ ._. This_DT
          analysis_NN was_VBD done_VBN for_IN the_DT 0_CD ._. 5_CD μg_NN group_NN as_RB well_RB ._. The_DT 0_CD ._. 1_CD
          μg_NN arrays_NNS were_VBD compared_VBN to_TO the_DT 0_CD ._. 5_CD μg_NN arrays_NNS from_IN the_DT
          same_JJ animal_NN ,_, to_TO determine_VB how_WRB well_RB these_DT two_CD amplified_VBN
          samples_NNS corresponded_VBD with_IN one_CD another_DT ._.
          Data_NNS from_IN each_DT RNA_NNP sample_NN size_NN group_NN were_VBD exported_VBN and_CC
          each_DT probe_NN set_VBN analyzed_VBD in_IN the_DT following_JJ ways_NNS :_:
          1_LS ._. The_DT number_NN of_IN GeneChips_NNP ®_NN on_IN which_WDT a_DT probe_NN set_VBN was_VBD
          detected_VBN within_IN each_DT of_IN the_DT treatment_NN groups_NNS (_( normal_JJ vs_NNS ._.
          deficient_NN diet_NN )_) was_VBD calculated_VBN ._. Each_DT present_JJ call_NN was_VBD
          assigned_VBN the_DT value_NN 1_CD and_CC each_DT marginal_JJ call_NN assigned_VBN
          0_CD ._. 51_CD ._. Only_RB probe_NN sets_NNS that_WDT are_VBP present_JJ in_IN at_IN least_JJS
          one-half_NN of_IN the_DT samples_NNS from_IN one_CD of_IN the_DT treatment_NN groups_NNS
          (_( either_CC normal_JJ or_CC deficient_NN diet_NN )_) were_VBD used_VBN for_IN further_RBR
          analysis_NN ,_, we_PRP call_VBP this_DT the_DT "_'' detection_NN filter_NN "_'' ._. Note_VB that_IN
          we_PRP did_VBD not_RB require_VB the_DT probe_NN set_VBN to_TO be_VB present_JJ in_IN both_DT
          treatment_NN groups_NNS ,_, just_RB in_IN one_CD ._. For_IN this_DT experiment_NN ,_, we_PRP
          required_VBD a_DT score_NN of_IN at_IN least_JJS 2_CD for_IN the_DT 10_CD μg_NN ,_, 0_CD ._. 1_CD μg_NN and_CC
          0_CD ._. 5_CD μg_NN groups_NNS (_( 4_CD GeneChips_NNP ®_NN in_IN each_DT treatment_NN group_NN )_) and_CC
          1_CD ._. 51_CD for_IN the_DT 2_CD μg_NN and_CC corresponding_JJ 6_CD -_: sample_NN subset_NN of_IN
          the_DT 10_CD μg_NN groups_NNS (_( 3_CD GeneChips_NNP ®_NN in_IN each_DT treatment_NN
          group_NN )_) ._.
          2_LS ._. The_DT sum_NN of_IN the_DT calls_NNS from_IN the_DT comparison_NN analyses_NNS
          was_VBD calculated_VBN ,_, using_VBG 1_CD for_IN increase_NN ,_, 0_CD ._. 5_CD for_IN marginal_JJ
          increase_NN ,_, 0_CD for_IN no_DT change_NN ,_, -_: 0_CD ._. 5_LS for_IN marginal_JJ decrease_NN ,_,
          and_CC -_: 1_CD for_IN decrease_NN ._.
          3_LS ._. The_DT mean_NN ,_, standard_JJ deviation_NN and_CC coefficient_NN of_IN
          variation_NN of_IN the_DT signal_NN for_IN each_DT probe_NN set_VBN within_IN each_DT
          treatment_NN group_NN (_( normal_JJ and_CC deficient_NN diet_NN )_) were_VBD
          calculated_VBN ._.
          4_LS ._. Student_NNP 's_POS t-test_JJ for_IN equal_JJ means_NNS with_IN the_DT
          assumption_NN of_IN unequal_JJ variance_NN [_NN 12_CD ]_NN was_VBD calculated_VBN to_TO
          test_VB for_IN significant_JJ differences_NNS in_IN signal_NN (_( expression_NN
          level_NN )_) between_IN the_DT normal_JJ and_CC vitamin_NN deficient_NN groups_NNS ._.
          This_DT test_NN was_VBD applied_VBN separately_RB to_TO the_DT signals_NNS and_CC the_DT
          log_NN 
          2_CD transformation_NN of_IN the_DT signals_NNS ._.
          5_LS ._. The_DT Wilcoxon_NNP rank-sum_JJ non-parametric_JJ test_NN for_IN equal_JJ
          means_NNS between_IN normal_JJ and_CC deficient_NN diet_NN groups_NNS [_NN 13_CD ]_NN was_VBD
          performed_VBN ._.
          6_CD ._. The_DT log_NN 
          2_CD ratio_NN (_( fold_VB change_NN )_) of_IN the_DT mean_NN
          signals_NNS for_IN normal_JJ 
          vs_NNS ._. deficient_NN diet_NN groups_NNS was_VBD
          calculated_VBN :_:
          log_VB 
          2_CD ratio_NN =_SYM log_VB 
          2_CD (_( (_( mean_NN of_IN signal_NN for_IN normal_JJ )_) /_NN (_( mean_NN
          of_IN signal_NN for_IN deficient_NN )_) )_)
          Changes_NNS within_IN an_DT RNA_NNP sample_NN size_NN group_NN between_IN normal_JJ
          and_CC deficient_NN diet_NN groups_NNS were_VBD assessed_VBN as_IN significant_JJ if_IN
          the_DT probe_NN set_VBN passed_VBD the_DT "_'' detection_NN filter_NN "_'' (_( #_# 1_CD above_IN )_)
          and_CC the_DT p-value_JJ was_VBD less_JJR than_IN 0_CD ._. 01_CD for_IN the_DT t-test_JJ using_VBG
          either_CC the_DT original_JJ signal_NN or_CC log_VB transformed_VBN signal_NN (_( #_# 4_CD
          above_IN )_) ._.
          Scatter_NNP plots_NNS comparing_VBG individual_JJ samples_NNS were_VBD
          created_VBN using_VBG Microsoft_NNP Excel_NNP ®_NN ._. SAS_NNP (_( SAS_NNP Institute_NNP Inc_NNP ._. ,_,
          Cary_NNP ,_, NC_NNP )_) was_VBD used_VBN for_IN univariate_NN analysis_NN of_IN the_DT signals_NNS
          for_IN each_DT RNA_NNP sample_NN size_NN group_NN ._.
        
        
          Distance_NNP of_IN target_NN from_IN 3_CD '_'' end_NN
          To_TO calculate_VB the_DT distance_NN of_IN the_DT target_NN from_IN the_DT 3_CD '_POS
          end_NN of_IN the_DT interrogated_VBN sequence_NN ,_, the_DT target_NN sequence_NN for_IN
          each_DT probe_NN set_VBN (_( supplied_VBN by_IN Affymetrix_NNP ;_:
          http_NN :_: /_NN /_NN www_NN ._. affymetrix_NN ._. comwas_NNS BLASTed_NNP [_NN 16_CD 17_CD ]_NN against_IN
          the_DT nr_NN (_( non-redundant_JJ )_) database_NN at_IN NCBI_NNP
          http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN ._. Using_VBG the_DT first_JJ (_( best_JJS )_)
          alignment_NN retumed_JJ ,_, the_DT distance_NN of_IN the_DT 5_CD '_POS end_NN of_IN the_DT
          target_NN sequence_NN from_IN the_DT 3_CD '_POS end_NN of_IN the_DT mRNA_NN or_CC EST_NNP in_IN the_DT
          nr_NN database_NN was_VBD calculated_VBN (_( Figure_NN 3_LS )_) ._. A_DT few_JJ of_IN the_DT
          alignments_NNS were_VBD rejected_VBN because_IN the_DT first_JJ alignment_NN was_VBD
          to_TO a_DT BAC_NNP sequence_NN or_CC to_TO the_DT wrong_JJ strand_NN ._.
        
      
      
        Abbreviations_NNP
        cRNA_NN ,_, complementary_JJ RNA_NNP
        cDNA_NN ,_, complementary_JJ DNA_NNP
        IVT_NNP ,_, 
        in_IN vitro_NN transcription_NN
        MAS_NNP 5_CD ,_, microarray_NN analysis_NN suite_NN version_NN 5_CD from_IN
        Affymetrix_NNP
        nr_NN ,_, non-redundant_JJ (_( nucleotide_NN database_NN at_IN NCBI_NNP )_)
        nt_RB ,_, nucleotides_NNS
      
      
        Authors_NNP '_'' contributions_NNS
        JNM_NNP participated_VBD in_IN the_DT design_NN of_IN the_DT study_NN ,_, performed_VBD
        statistical_JJ analysis_NN and_CC drafted_VBD the_DT manuscript_NN ._. REJ_NNP and_CC
        CRN_NNP carried_VBD out_RP the_DT biochemistry_NN and_CC aided_VBN in_IN optimizing_VBG
        the_DT methods_NNS ._. DWC_NNP designed_VBD and_CC coordinated_VBN the_DT original_JJ
        dietary_JJ study_NN and_CC provided_VBD the_DT total_JJ RNA_NNP for_IN this_DT work_NN ._. HJE_NNP
        conceived_VBD the_DT study_NN ,_, and_CC participated_VBD in_IN its_PRP$ design_NN ,_,
        coordination_NN ,_, analysis_NN and_CC writing_VBG ._. All_DT authors_NNS read_VBP and_CC
        approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
